<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001220.pub2" GROUP_ID="HIV" ID="437800042109063804" MERGED_FROM="" MODIFIED="2011-02-18 16:10:33 +0100" MODIFIED_BY="Tara Horvath" REVIEW_NO="02" REVMAN_SUB_VERSION="5.0.25" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.2">
<COVER_SHEET MODIFIED="2011-02-18 16:10:33 +0100" MODIFIED_BY="Tara Horvath">
<TITLE MODIFIED="2010-08-26 10:38:02 -0700" MODIFIED_BY="[Empty name]">Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection</TITLE>
<CONTACT MODIFIED="2011-02-18 16:10:33 +0100" MODIFIED_BY="Tara Horvath"><PERSON ID="02B990AD82E26AA200DA2AF3BF9E887C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lisa</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Butler</LAST_NAME><POSITION>Assistant Professor of Epidemiology</POSITION><EMAIL_1>lbutler@psg.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Global Health Sciences</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>50 Beale Street</ADDRESS_1><ADDRESS_2>Suite 1200</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94105</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2011-02-18 16:10:33 +0100" MODIFIED_BY="Tara Horvath"><PERSON ID="92639628392081628199100806195210" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Brian</FIRST_NAME><MIDDLE_INITIALS>E</MIDDLE_INITIALS><LAST_NAME>Ng</LAST_NAME><EMAIL_1>ng.brian.e@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>School of Population and Public Health</DEPARTMENT><ORGANISATION>The University of British Columbia</ORGANISATION><CITY>Vancouver</CITY><REGION>BC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="02B990AD82E26AA200DA2AF3BF9E887C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lisa</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Butler</LAST_NAME><POSITION>Assistant Professor of Epidemiology</POSITION><EMAIL_1>lbutler@psg.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Global Health Sciences</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>50 Beale Street</ADDRESS_1><ADDRESS_2>Suite 1200</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94105</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY></ADDRESS></PERSON><PERSON ID="17315" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Tara</FIRST_NAME><LAST_NAME>Horvath</LAST_NAME><POSITION>co-Managing Editor, Cochrane HIV/AIDS Group</POSITION><EMAIL_1>thorvath@psg.ucsf.edu</EMAIL_1><URL>http://www.igh.org/Cochrane</URL><ADDRESS><DEPARTMENT>Global Health Sciences</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>50 Beale Street</ADDRESS_1><ADDRESS_2>Suite 1200</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94105</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+415-597-8208</PHONE_1><FAX_1>+415-597-8299</FAX_1></ADDRESS></PERSON><PERSON ID="7065" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>George</FIRST_NAME><MIDDLE_INITIALS>W</MIDDLE_INITIALS><LAST_NAME>Rutherford</LAST_NAME><POSITION>Co-ordinating Editor, Cochrane HIV/AIDS Group</POSITION><EMAIL_1>GRutherford@psg.ucsf.edu</EMAIL_1><ADDRESS><DEPARTMENT>Global Health Sciences</DEPARTMENT><ORGANISATION>University of California, San Francisco</ORGANISATION><ADDRESS_1>50 Beale Street</ADDRESS_1><ADDRESS_2>Suite 1200</ADDRESS_2><CITY>San Francisco</CITY><ZIP>94105</ZIP><REGION>California</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 415 597 9108</PHONE_1><FAX_1>+1 415 597 8299</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-02-15 19:54:45 -0800" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="15" MONTH="2" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="16" MONTH="8" YEAR="2010"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="16" MONTH="8" YEAR="2012"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2004"/>
</DATES>
<WHATS_NEW MODIFIED="2011-02-17 10:10:36 -0800" MODIFIED_BY="Tara Horvath">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-02-17 10:10:36 -0800" MODIFIED_BY="Tara Horvath">
<DATE DAY="17" MONTH="2" YEAR="2011"/>
<DESCRIPTION>
<P>Complete revision and update; new author team.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2011-02-16 15:56:40 -0800" MODIFIED_BY="Tara Horvath">
<DATE DAY="16" MONTH="2" YEAR="2011"/>
<DESCRIPTION>
<P>Complete revision and update; new author team.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-08-25 11:16:10 -0700" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-25 11:16:10 -0700" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="26" MONTH="2" YEAR="2004"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2011-02-14 15:36:42 -0800" MODIFIED_BY="Tara Horvath">
<INTERNAL_SOURCES MODIFIED="2011-02-14 15:36:42 -0800" MODIFIED_BY="Tara Horvath">
<SOURCE MODIFIED="2011-02-14 15:36:42 -0800" MODIFIED_BY="Tara Horvath">
<NAME>Global Health Sciences, University of California, San Francisco</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-02-16 22:17:11 -0800" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-02-16 22:16:35 -0800" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-08-16 09:23:05 -0700" MODIFIED_BY="[Empty name]">Population-based interventions for reducing HIV infection</TITLE>
<SUMMARY_BODY MODIFIED="2011-02-16 22:16:35 -0800" MODIFIED_BY="[Empty name]">
<P>Community- or population-based sexually transmitted infection control does not appear to be an effective HIV prevention strategy in most settings. In the early 1990s, improved STI treatment services were shown to reduce HIV incidence in northern Tanzania, in an environment characterised by an emerging HIV epidemic, where STI treatment services were poor and where STIs were highly prevalent. Subsequent trials, however, failed to confirm these findings and also failed to show a substantial benefit for community-wide presumptive treatment for STIs. This is likely due to the endemic nature of HIV and relatively low incidence of STIs in these populations. There are, however, other good reasons as to why STI treatment services should be strengthened and the available evidence suggests that when an intervention is applied and accepted in a community, it can improve the quality of services provided. The trial in Masaka District, Uganda showed an increase in the use of condoms, a marker for less risky sexual behaviours, although a newer study by Gregson conducted in Zimbabwe suggested no effect. With the last three trials having shown disappointing results with respect to HIV prevention, it is unlikely that further community trials will be conducted, let alone yield different results. Future trials of biomedical interventions that involve individual randomisation, however, may represent an opportunity to reexamine presumptive treatment of STIs. Such trials should also aim to measure a range of factors that include health-seeking behaviour and quality of treatment, as well as HIV, STI and other biological endpoints.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-02-16 21:50:10 -0800" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-02-16 21:49:18 -0800" MODIFIED_BY="[Empty name]">
<P>The transmission of sexually transmitted infections (STIs) is closely related to the sexual transmission of human immunodeficiency virus (HIV). Similar risk behaviours, such as frequent unprotected intercourse with different partners, place people at high risk of HIV and STIs, and there is clear evidence that many STIs increase the likelihood of HIV transmission. STI control, especially at the population or community level, may have the potential to contribute substantially to HIV prevention.</P>
<P>This is an update of an existing Cochrane review. The review's search methods were updated and its inclusion and exclusion criteria modified so that the focus would be on one well-defined outcome. This review now focuses explicitly on population-based biomedical interventions for STI control, with change in HIV incidence being an outcome necessary for a study's inclusion.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-02-16 15:04:03 -0800" MODIFIED_BY="Tara Horvath">
<P>To determine the impact of population-based biomedical STI interventions on the incidence of HIV infection.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-02-16 17:46:55 -0800" MODIFIED_BY="Tara Horvath">
<P>We searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science/Social Science, PsycINFO, and Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS), for the period of 1 January1980 - 16 August 2010. We initially identified 6003 articles and abstracts. After removing 776 duplicates, one author (TH) removed an additional 3268 citations that were clearly irrelevant. Rigorously applying the inclusion criteria, three authors then independently screened the remaining 1959 citations and abstracts. Forty-six articles were chosen for full-text scrutiny by two authors. Ultimately, four studies were included in the review.</P>
<P>We also searched the Aegis database of conference abstracts, which includes the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Conference (IAC), and International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS) meetings from their inception dates (1993, 1985 and 2001, respectively) through 2007. We manually searched the web sites of those conferences for more recent abstracts (up to 2010, 2010 and 2009, respectively)  </P>
<P>In addition to searching the clinical trials registry at the US National Institutes of Health, we also used the metaRegister of Controlled Trials.</P>
<P>We checked the reference lists of all studies identified by the above methods.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-02-13 09:59:06 -0800" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials involving one or more biomedical interventions in general populations (as opposed to occupationally or behaviourally defined groups, such as sex workers) in which the unit of randomisation was either a community or a treatment facility and in which the primary outcome was incident HIV infection. The term "community" was interpreted to include a group of villages, an arbitrary geographical division, or the catchment population of a group of health facilities.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-02-16 21:49:57 -0800" MODIFIED_BY="[Empty name]">
<P>Three authors (BN, LB, TH) independently applied the inclusion criteria to potential studies, with any disagreements resolved by discussion. Trials were examined for completeness of reporting. Data were abstracted independently using a standardised abstraction form.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-02-16 21:50:10 -0800" MODIFIED_BY="[Empty name]">
<P>We included four trials. One trial evaluated mass treatment of all individuals in a particular community. The other three trials evaluated various combinations of improved syndromic STI management in clinics, STI counselling, and STI treatment.</P>
<P>In the mass treatment trial in rural southwestern Uganda, after three rounds of treatment of all community members for STIs, the adjusted rate ratio (aRR) of incident HIV infection was 0.97 (95% CI 0.81 - 1.2), indicating no effect of the intervention. The three STI management intervention studies were all conducted in rural parts of Africa. One study, in northern Tanzania, showed that the incidence of HIV infection in the intervention groups (strengthened syndromic management of STIs in primary care clinics) was 1.2% compared with 1.9% in the control groups (aRR = 0.58, 95% CI 0.42 - 0.79), corresponding to a 42% reduction (95% CI 21.0% - 58.0%) in HIV incidence in the intervention group. Another study, conducted in rural southwestern Uganda, showed that the aRR of behavioural intervention and STI management compared to control on HIV incidence was 1.00 (95% CI 0.63 - 1.58). In the third STI management trial, in eastern Zimbabwe, there was no effect of the intervention on HIV incidence (aRR = 1.3, 95% CI 0.92 - 1.8). These are consistent with data from the mass treatment trial showing no intervention effect. Overall, pooling the data of the four studies showed no significant effect of any intervention (rate ratio [RR] = 0.97, 95% CI 0.78 - 1.2).</P>
<P>Combining the mass treatment trial and one of the STI management trials, we find that there is a significant 12.0% reduction in the prevalence of syphilis for those receiving a biomedical STI intervention (RR 0.88, 95% CI 0.80 - 0.96). For gonorrhoea, we find a statistically significant 51.0% reduction in its prevalence in those receiving any of these interventions (RR 0.49, 95% CI 0.31 - 0.77). Finally, for chlamydia, we found no significant difference between any biomedical intervention and control (RR 1.03, 95% CI 0.77 - 1.4).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-02-16 12:05:00 -0800" MODIFIED_BY="Tara Horvath">
<P>We failed to confirm the hypothesis that STI control is an effective HIV prevention strategy. Improved STI treatment services were shown in one study to reduce HIV incidence in an environment characterised by an emerging HIV epidemic (low and slowly rising prevalence), where STI treatment services were poor and where STIs were highly prevalent; Incidence was not reduced in two other settings. There is no evidence for substantial benefit from a presumptive treatment intervention for all community members. There are, however, other compelling reasons why STI treatment services should be strengthened, and the available evidence suggests that when an intervention is accepted it can substantially improve quality of services provided.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-02-16 22:17:11 -0800" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2011-02-16 21:53:05 -0800" MODIFIED_BY="[Empty name]">
<P>Nearly 30 years after the human immunodeficiency virus (HIV) was identified, there are still close to 3 million people newly infected with HIV each year (<LINK REF="REF-UNAIDS-2008" TYPE="REFERENCE">UNAIDS 2008</LINK>), and the large majority of these infections are acquired sexually. According to 1999 World Health Organization (WHO) estimates, 340 million new cases of chlamydia, gonorrhoea, syphilis and trichomoniasis occur annually throughout the world (<LINK REF="REF-WHO-1999" TYPE="REFERENCE">WHO 1999</LINK>). Globally, almost 57 million disability-adjusted life years (DALYs) are lost to STIs (<LINK REF="REF-DCPP-2007" TYPE="REFERENCE">DCPP 2007</LINK>). The burden is highest in sub-Saharan Africa, where the combined incidence of these four infections is estimated at 257 per 1000 population at risk (<LINK REF="REF-WHO-2001" TYPE="REFERENCE">WHO 2001</LINK>). In sub-Saharan Africa, heterosexual men and women make up the large majority of HIV cases. In 2007, UNAIDS estimated that about 67% of the 33 million people infected with HIV live in sub-Saharan Africa (<LINK REF="REF-UNAIDS-2008" TYPE="REFERENCE">UNAIDS 2008</LINK>). One recently published randomised controlled trial conducted in South Africa identified high incidence rates in the control arm of 9.1 per 100 woman-years, suggesting continued high levels of transmission (<LINK REF="REF-Abdool-Karim-2010" TYPE="REFERENCE">Abdool Karim 2010</LINK>). Interventions that prevent or lessen the risk of sexual transmission, therefore, have the potential to decrease the burden of HIV.</P>
<P>STIs and HIV are interdependent. Similar risk behaviours, such as frequent unprotected intercourse with different partners, place people at high risk of STI and HIV infection, and there is clear evidence that certain bacterial and viral STIs increase the likelihood of HIV transmission (<LINK REF="REF-Wasserheit-1992" TYPE="REFERENCE">Wasserheit 1992</LINK>, <LINK REF="REF-Royce-1997" TYPE="REFERENCE">Royce 1997</LINK>, <LINK REF="REF-Fleming-1999" TYPE="REFERENCE">Fleming 1999</LINK>). Several observational studies have demonstrated strong associations between ulcerative and non-ulcerative STIs and HIV infection (<LINK REF="REF-Cameron-1989" TYPE="REFERENCE">Cameron 1989</LINK>, <LINK REF="REF-Laga-1993" TYPE="REFERENCE">Laga 1993</LINK>). There is biological evidence, too, that the presence of an STI increases shedding of HIV, and that STI treatment reduces HIV shedding (<LINK REF="REF-Cohen-1997" TYPE="REFERENCE">Cohen 1997</LINK>, <LINK REF="REF-Robinson-1997" TYPE="REFERENCE">Robinson 1997</LINK>). Another trial, in which individuals were randomised to receive antibiotic prophylaxis or placebo, however, showed no evidence that prophylaxis reduces the risk of HIV infection (<LINK REF="REF-Kaul-2002" TYPE="REFERENCE">Kaul 2002</LINK>). This study was ultimately not included in this review as it focused on sex workers (see inclusion/exclusion criteria below).</P>
<P>Prevention of HIV infection depends on promotion of safer sexual behaviour (e.g. having fewer sexual partners) (<LINK REF="REF-Lin-2008" TYPE="REFERENCE">Lin 2008</LINK>), use of condoms (<LINK REF="REF-Davis-1999" TYPE="REFERENCE">Davis 1999</LINK>), the early and effective treatment of STIs (<LINK REF="REF-Workowski-2006" TYPE="REFERENCE">Workowski 2006</LINK>), male circumcision (protective for men only, <LINK REF="REF-Auvert-2005" TYPE="REFERENCE">Auvert 2005</LINK>, <LINK REF="REF-Bailey-2007" TYPE="REFERENCE">Bailey 2007</LINK>, <LINK REF="REF-Gray-2007" TYPE="REFERENCE">Gray 2007</LINK>), and a low viral load in the infected partner (<LINK REF="REF-Attia-2009" TYPE="REFERENCE">Attia 2009</LINK>). STI control has the potential to contribute substantially to HIV prevention because, in certain situations, up to 90% of new HIV infections may be attributable to STIs as co-factors in the early phase of an HIV epidemic (<LINK REF="REF-Robinson-1997" TYPE="REFERENCE">Robinson 1997</LINK>), and because substantial and sustained changes in sexual behaviour are difficult to attain.</P>
<P>STI screening and control in the general population by itself may reduce the burden of STIs and their complications (<LINK REF="REF-Scholes-1996" TYPE="REFERENCE">Scholes 1996</LINK>, <LINK REF="REF-Ostergaard-2000" TYPE="REFERENCE">Ostergaard 2000</LINK>). However, a recent systematic review (<LINK REF="REF-Low-2009" TYPE="REFERENCE">Low 2009</LINK>) found a paucity of evidence for screening women for chlamydia under the age of 25. Nonetheless, STIs are responsible for a considerable burden of acute illness. Although the majority of women with STIs are asymptomatic, about 10% develop pelvic inflammatory disease (<LINK REF="REF-Oakeshott-2010" TYPE="REFERENCE">Oakeshott 2010</LINK>). Other complications, especially in women, can occur years after the initial infection, causing chronic pelvic pain, ectopic pregnancy, infertility and death (<LINK REF="REF-Wasserheit-1989" TYPE="REFERENCE">Wasserheit 1989</LINK>). Untreated syphilis in pregnancy can lead to perinatal transmission and miscarriage, intrauterine growth retardation, stillbirth, hydrops fetalis, prematurity and neonatal death (<LINK REF="REF-Walker-2007" TYPE="REFERENCE">Walker 2007</LINK>). Further trials are needed to determine whether STI treatment and control is effective in reducing the burden of illness from STIs.</P>
<P>To have maximal impact, STI interventions will likely need to be applied to whole populations. In this way the "mass effect" of the intervention on HIV transmission can be anticipated. The mass effect refers to the combined effect of reducing HIV shedding among HIV infected people who have an STI, and reducing the susceptibility of HIV-uninfected people with an STI to acquiring HIV infection (<LINK REF="REF-Mabey-1996" TYPE="REFERENCE">Mabey 1996</LINK>). If coverage of an intervention is high enough it may achieve the "mass effect" whereby the overall level of transmission of STIs in the population is reduced. In fact, it has been shown that decreases in community HIV viral load is associated with decreases in HIV incidence (<LINK REF="REF-Das-2010" TYPE="REFERENCE">Das 2010</LINK>). Although ecological in nature, the results of <LINK REF="REF-Das-2010" TYPE="REFERENCE">Das 2010</LINK> at least warrant further study.</P>
<P>Potential population-based STI interventions include campaigns aimed at promoting safer sexual behaviour and better STI treatment-seeking behaviour, improved STI treatment services (including improved attitudes of care providers, improved case management and contact treatment), integration of STI case findings in family planning and antenatal care services, STI screening programmes, and mass treatment of whole communities for STIs. We define population-based biomedical STI interventions as programmes and activities that include treatment or prophylaxis of STIs with antibiotics, antiviral medications or devices such as condoms or diaphragms. Such programs and activities may or may not encompass other population-based STI interventions such as those listed above. In this review we examine the evidence that population-based biomedical STI interventions can lead to decreased HIV transmission.</P>
<P>This is an update of an existing Cochrane review (<LINK REF="REF-Wilkinson-2001" TYPE="REFERENCE">Wilkinson 2001</LINK>, originally updated in <LINK REF="REF-Sangani-2004" TYPE="REFERENCE">Sangani 2004</LINK>). We have updated our search methods and modified our inclusion and exclusion criteria to better focus on one well-defined outcome: HIV incidence.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2011-02-13 12:09:46 -0800" MODIFIED_BY="[Empty name]">
<P>The primary objective is to determine the impact of population-based biomedical STI interventions, as defined above, on the incidence of HIV infection in the general population.</P>
<P>Secondary objectives are to determine the impact of population-based biomedical STI interventions on the following outcomes:<BR/>
</P>
<UL>
<LI>reduction in the incidence of STIs </LI>
<LI>increase in the utilisation of STI treatment services and improved rates of partner treatment</LI>
<LI>improvement in the quality of STI treatment services</LI>
<LI>increase in safer sexual behaviour in the community, including increased condom use</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2011-02-16 21:54:14 -0800" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-02-16 21:53:46 -0800" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2011-02-16 21:53:46 -0800" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials in which the unit of randomisation was either a community or a treatment facility. Studies had to have HIV incidence as a primary outcome.</P>
<P>We interpreted the term 'community' to include a group of villages, an arbitrary geographical division, or the catchment population of a group of health facilities. We excluded studies that were based on schools, bars, restaurants, community centres or any other similar venues, as patrons who frequent these establishments may have different characteristics from those in the general population. We also excluded studies that were focused on a single high-risk subpopulation, such as sex workers or men who have sex with men.</P>
<P>We updated our inclusion and exclusion criteria from <LINK REF="REF-Wilkinson-2001" TYPE="REFERENCE">Wilkinson 2001</LINK> and <LINK REF="REF-Sangani-2004" TYPE="REFERENCE">Sangani 2004</LINK> to allow for a more rigorous search and more narrowly-defined interventions. Thus, we excluded two studies (<LINK REF="STD-Garcia-1998" TYPE="STUDY">Garcia 1998</LINK> and <LINK REF="STD-Mayaud-1997" TYPE="STUDY">Mayaud 1997</LINK>) that were included in the 2004 review as they did not fit the revised inclusion and exclusion criteria (HIV incidence as an endpoint).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2010-08-19 15:27:15 -0700" MODIFIED_BY="[Empty name]">
<P>General adult populations and people with STIs. </P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-02-13 12:09:42 -0800" MODIFIED_BY="[Empty name]">
<P>Any population-based biomedical STI intervention including, but not exclusive to: 1) improved STI treatment services and 2) mass treatment of whole communities (that is, all individuals symptomatic and asymptomatic in a community who meet the study's criteria for treatment for STI).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-02-16 14:43:15 -0800" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-02-16 14:41:57 -0800" MODIFIED_BY="[Empty name]">
<P>
<B>1. Incidence of HIV infection:</B>
</P>
<UL>
<LI>incidence of HIV infection in a representative community sample</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2011-02-16 14:43:15 -0800" MODIFIED_BY="[Empty name]">
<P>
<B>2. Incidence or Prevalence of STIs:</B>
<BR/>
</P>
<UL>
<LI>incidence of STIs in a representative community sample</LI>
<LI>prevalence of STIs in a representative community sample</LI>
</UL>
<P>
<BR/>
<B>3. Safer sexual behaviour:</B>
<BR/>
</P>
<UL>
<LI>proportion of people in a representative sample that report a reduction in rate of partner change</LI>
<LI>proportion of people in a representative sample reporting regular condom use with casual partners</LI>
<LI>proportion of people in a representative sample reporting two or more sexual partners in the past year</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-02-16 21:54:14 -0800" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2011-02-16 21:54:14 -0800" MODIFIED_BY="[Empty name]">
<P>We searched PubMed, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science/Social Science, PsycINFO, and Literatura Latino Americana e do Caribe em Ciências da Saúde (LILACS), for the period of 1 January1980 - 16 August 2010. The detailed search strategy can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The search strategy was updated from that used in 2001 and 2004 to be more comprehensive. The inclusion and exclusion criteria are summarised below:</P>
<P>
<B>Inclusion criteria:</B>
</P>
<UL>
<LI>Randomised controlled trials in which the unit of randomisation is a community, as defined above.</LI>
<LI>Intervention is any population-based biomedical STI program, including improved STI management and mass antibiotic treatment of populations</LI>
<LI>Primary outcome is HIV incidence</LI>
</UL>
<P>
<B>Exclusion criteria</B>:</P>
<UL>
<LI>Trials in which individuals, and not communities, were randomised.</LI>
<LI>Trials based in sub-populations such as sex workers, injection drug users, men who have sex with men, adolescents, etc.</LI>
<LI>Trials with interventions that were primarily behavioural in nature.</LI>
</UL>
<P>Searches were done without limits to language or setting.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2011-02-14 15:00:32 -0800" MODIFIED_BY="Tara Horvath">
<P>We searched the Aegis database of conference abstracts (<A HREF="http://www.aegis.org">www.aegis.org</A>), which includes the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Conference (IAC), and International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS) meetings from their inception dates (1993, 1985 and 2001, respectively) through 2007. We manually searched the web sites of those conferences for more recent abstracts (up to 2010, 2010 and 2009, respectively)  </P>
<P>In addition to searching <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A> at the US National Institutes of Health, we also used the metaRegister of Controlled Trials (<A HREF="http://www.controlled-trials.com/mrct">http://www.controlled-trials.com/mrct</A>) to search the following registries of ongoing research:</P>
<UL>
<LI>International Standard Randomised Controlled Trial Number Register (ISRCTN)</LI>
<LI>Action Medical Research (UK)</LI>
<LI>Medical Research Council (UK)</LI>
<LI>NIHR Health Technology Assessment Programme (HTA) (UK)</LI>
<LI>The Wellcome Trust (UK)</LI>
<LI>UK trials (UK)</LI>
</UL>
<P>We checked the reference lists of all studies identified by the above methods.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-02-16 17:49:04 -0800" MODIFIED_BY="Tara Horvath">
<P>Two authors independently applied the inclusion criteria to potential studies, with any disagreements resolved by discussion. Trials recognised as randomised controlled clinical trials were examined for completeness of reporting. The risk of bias in each trial was assessed by the same two authors, and details were recorded of randomisation, allocation method, blinding, use of intention-to-treat analysis and the number of patients lost to follow-up using standard guidelines of the Cochrane Collaboration (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
<STUDY_SELECTION MODIFIED="2011-02-16 17:49:03 -0800" MODIFIED_BY="Tara Horvath">
<P>The total number of search results was 6003. After removing 776 duplicates, TH removed an additional 3268 citations that were clearly irrelevant. Rigorously applying the inclusion criteria, BN, LB, and TH then independently screened the remaining 1959 citations and abstracts. Forty-six articles were chosen for full-text scrutiny. LB and BN then independently reviewed each of the 46 articles and rigorously applied the inclusion and exclusion criteria. Any disagreements were resolved by discussion with GWR and TH. Ultimately, four studies were included in the review. <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> summarises our screening and selection process.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-02-16 17:49:04 -0800" MODIFIED_BY="Tara Horvath">
<P>After the searches and article screening, two authors (LB and BN) independently double-coded and entered information from each selected study onto standardised data extraction forms. Extracted information included:<B> </B>
</P>
<UL>
<LI>Study objectives</LI>
<LI>Study location and population characteristics</LI>
<LI>A description of the intervention</LI>
<LI>Methods, including the study design, sample size, and length of follow-up</LI>
<LI>Analysis and results</LI>
<LI>Conclusions</LI>
<LI>Definitions of key outcomes</LI>
<LI>Limitations of the study (as identified by the study authors and the reviewers)</LI>
<LI>Funding source</LI>
<LI>Other references for follow-up</LI>
<LI>Whether there was adequate sequence generation</LI>
<LI>Whether there was adequate allocation concealment</LI>
<LI>Whether there was adequate blinding</LI>
<LI>Whether incomplete data were adequately addressed</LI>
<LI>Whether the study was free of selective reporting</LI>
<LI>Whether the study was free of other biases</LI>
<LI>Whether the study had pre- and post-intervention data</LI>
<LI>Whether the study had a control group</LI>
<LI>Whether the study had a cohort</LI>
<LI>Whether the intervention and comparison groups were equivalent at baseline on socio-demographics</LI>
<LI>Whether the intervention and comparison groups were equivalent at baseline with respect to outcome measures</LI>
<LI>Whether participants were randomly selected</LI>
<LI>Whether communities were randomly allocated to the intervention</LI>
<LI>Whether potential confounders were controlled for</LI>
<LI>Whether follow-up rate was 75% or more</LI>
</UL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-02-16 11:01:16 -0800" MODIFIED_BY="Tara Horvath">
<P>We used the Cochrane Collaboration's tool for assessing risk of bias for individual studies. See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>. The tool assesses for bias across six categories: sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data, selective outcome reporting, and other sources of bias. The following, taken from <LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>, describes how we rated each study in each category.</P>
<P>
<B>Sequence generation</B>
</P>
<UL>
<LI>Adequate: investigators described a random component in the sequence generation process, such as the use of random number table, coin tossing, card or envelope shuffling, etc.</LI>
<LI>Inadequate: investigators described a non-random component in the sequence generation process, such as the use of odd or even date of birth, algorithm based on the day or date of birth, hospital, or clinic record number.</LI>
<LI>Unclear: insufficient information to permit judgement of the sequence generation process.</LI>
</UL>
<P>
<B>Allocation concealment</B>
</P>
<UL>
<LI>Adequate: participants and the investigators enrolling participants cannot foresee assignment (e.g., central allocation; or sequentially numbered, opaque, sealed envelopes).</LI>
<LI>Inadequate: participants and investigators enrolling participants can foresee upcoming assignment (e.g., an open random allocation schedule, a list of random numbers); or envelopes were unsealed or non-opaque or not sequentially numbered.</LI>
<LI>Unclear: insufficient information to permit judgement of the allocation concealment or the method not described.</LI>
</UL>
<P>
<B>Blinding</B>
</P>
<UL>
<LI>Adequate: blinding of the participants, key study personnel, and outcome assessor, and unlikely that the blinding could have been broken. No blinding in the situation where non-blinding is not likely to introduce bias.</LI>
<LI>Inadequate: no blinding or incomplete blinding when the outcome is likely to be influenced by lack of blinding.</LI>
<LI>Unclear: insufficient information to permit judgement of adequacy or otherwise of the blinding.</LI>
</UL>
<P>
<B>Incomplete outcome data</B>
</P>
<UL>
<LI>Adequate: no missing outcome data, reasons for missing outcome data unlikely to be related to true outcome, or missing outcome data balanced in number across groups.</LI>
<LI>Inadequate: reason for missing outcome data likely to be related to true outcome, with either imbalance in number across groups or reasons for missing data.</LI>
<LI>Unclear: insufficient reporting of attrition or exclusions.</LI>
</UL>
<P>
<B>Selective reporting</B>
</P>
<UL>
<LI>Adequate: a protocol is available which clearly states the primary outcome as the same as in the final trial report.</LI>
<LI>Inadequate: the primary outcome differs between the protocol and final trial report.</LI>
<LI>Unclear: no trial protocol is available or there is insufficient reporting to determine if selective reporting is present.</LI>
</UL>
<P>
<B>Other forms of bias (e.g., early stopping of trial, fraudulent activity, extreme baseline imbalance, or bias related to specific study design)</B>
</P>
<UL>
<LI>Adequate: there is no evidence of bias from other sources.</LI>
<LI>Inadequate: there is potential bias present from other sources.</LI>
<LI>Unclear: insufficient information to permit judgment of adequacy or otherwise of other forms of bias.</LI>
</UL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2010-08-20 09:57:29 -0700" MODIFIED_BY="[Empty name]">
<P>We used Review Manager 5 provided by the Cochrane Collaboration for statistical analysis. We summarized outcomes with relative risks and 95% confidence intervals (CIs).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2010-08-20 09:58:49 -0700" MODIFIED_BY="[Empty name]">
<P>The unit of analysis was individuals. The unit of randomisation in each study, however, was communities.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-02-14 14:54:17 -0800" MODIFIED_BY="Tara Horvath">
<P>Missing data were not analysed. Authors were not contacted about missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-02-16 13:04:30 -0800" MODIFIED_BY="Tara Horvath">
<P>We examined heterogeneity among trials using the &#967;<SUP>2 </SUP>statistic with a significance level of 0.10 and the I-squared statistic. We interpreted an I<SUP>2</SUP> estimate greater than 50% as indicating moderate or high levels of heterogeneity. Because of the small number of studies, it is difficult to interpret the I<SUP>2</SUP> value. These numbers were reported for the sake of completeness. Sensitivity analysis, therefore, was not done.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2011-02-16 12:40:23 -0800" MODIFIED_BY="Tara Horvath">
<P>We minimised the potential for publication bias by our comprehensive search strategy that included published and unpublished literature, without limitations of language or setting.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-02-16 14:41:24 -0800" MODIFIED_BY="[Empty name]">
<P>The correct analysis of data from cluster-randomised trials such as the four included in this review involves the calculation of the intracluster correlation coefficient (ICC) for each study. The ICC is then used to calculate the design-effect which is then used to calculate the effective sample sizes of intervention and control groups (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). The ICCs for the primary outcome (HIV incidence) for three of the four studies (<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>, <LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>, and <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>) can be found in <LINK REF="REF-Todd-2003" TYPE="REFERENCE">Todd 2003</LINK>. Because the ICC for the fourth study (<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>) could not be found, it was approximated by using the ICC for the Grosskurth trial, as the design and interventions are most similar in these two.</P>
<P>Because the ICCs for the secondary outcomes could not be easily found, calculated or estimated, the original sample sizes were used to calculate our effect measures. This will result in over-precise results (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>), but the effect measure remains unbiased.</P>
<P>When interventions and study populations were sufficiently similar across different studies, we statistically pooled the outcomes and examined the differences between the two models using both fixed and random-effects models.  Since there were no significant differences between the two models, final results are presented using fixed-effects models where there is low heterogeneity, and random-effects models where there is moderate or high heterogeneity between studies.</P>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-02-16 22:17:06 -0800" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2011-02-16 22:16:58 -0800" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>: Between 1991 and 1994, Grosskurth and colleagues randomised 12 communities and their associated primary care clinics in Mwanza, Tanzania, to receive improved STI case management, or not to receive it. The intervention comprised establishing a STI reference clinic in the district, staff training, and providing a regular supply of basic drugs, regular supervision of clinic staff, and STI health education. The 12 communities were paired based upon baseline HIV and STI prevalence and risk factors for infection, proximity to roads, geography, and prior STI clinic attendance rates. In each pair one community was randomly chosen to receive the intervention and the other to serve as the control. Outcomes were measured among approximately 12,000 adults aged 15-54 years (1000 randomly selected from each community, residing within a 90 minute walk of each clinic). HIV incidence and STI prevalence were measured two years post-intervention.</P>
<P>
<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>: Between 1994 and 1998, Wawer and colleagues conducted a randomised controlled single-masked community-based trial of intensive STI control via home-based mass antibiotic treatment in Rakai, Uganda. Ten community clusters were randomly assigned to intervention (treatment of all consenting adults aged 15-59 years with azithromycin, ciprofloxacin, and metronidazole, irrespective of symptoms) or control (treatment with vitamins/antihelminthic drugs). Treatment was given as single dose under direct observation every 10 months. The 10 community clusters each comprised 4-7 contiguous villages that encompassed social and sexual networks. Clusters were grouped into blocks based on projected HIV prevalence and were paired based on HIV prevalence. Communities and participants were blinded to the intervention, but study personnel were not. Participants included all permanent resident adults aged 15-59 years who consented to the trial. Participants comprised an open cohort, including newly arrived residents at each study round. All households were visited every 10 months at which time treatment was given, biological samples for HIV and STI taken, and a questionnaire administered. All participants in both arms of the study received identical education on HIV prevention, confidential HIV counselling and testing services, free condoms, and free health care. All participants were also advised to seek treatment for STI symptoms between study rounds. Mass treatment was provided to over 80% of eligible adults present in the community each study round. Results of the first three study rounds were presented as the Data Safety and Monitoring Board (DSMB) invoked a predetermined stopping rule at this stage. Outcome measures were HIV incidence and STI prevalence.</P>
<P>
<LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>: Between 1994 and 2000, Kamali and colleagues randomised all adults living in 18 communities in the Masaka district of rural Uganda to three groups. The total population was 96,000 aged 13 and older. The aim was to assess the effect of different interventions on the primary outcome, the incidence of HIV. The secondary outcomes were the incidence of other STDs. These included herpes simplex type 2, active syphilis, prevalence of gonorrhoea and chlamydia, reported genital ulcers and markers of behavioral change. Group A received behavioural interventions alone consisting of information, education. Group B received behavioral and STI interventions and Group C received routine government health services. The study communities were individually matched in triplets by the type of main road passing through, distance from the district capital and quality of the local government health facility. They formed a total of 6 triplets. Interventions were tested at baseline (April 1994 - November 1996), round 2 (December 1996 - December 1998) and round 3 (January 1999 - June 2000) with questionnaires and laboratory testing.</P>
<P>
<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK> Between 1998 and 2003, Gregson and colleagues conducted a randomised trial to examine if a program of community-based peer education, free condom distribution, income-generating projects and improved clinic-based STI treatment and counselling services would have an impact on the incidence of HIV-1 measured over a three-year period in eastern Zimbabwe. Twelve total communities were paired, with matching on socioeconomic status. Within each pair, one community was assigned at random to receive the additional intervention, and the other to be the control. Outcomes consisted of incidence rate of HIV-1, self-reported STI symptoms, and high-risk sexual behaviours.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-02-16 22:17:06 -0800" MODIFIED_BY="[Empty name]">
<P>See <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> for graphic summaries of our assessment, using the Cochrane Collaboration's tool, of the risk of bias in each study and across all studies.</P>
<P>
<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>: Allocation sequence generation is unclear. Although the authors state that paired communities were randomised, it is unclear how this randomisation was achieved. It is also unclear if the allocation sequence was concealed from those assigning the groups. The study was randomised between pre-determined village pairs with pairing dependent on geographical characteristics, proximity to roads, and baseline HIV prevalence. The study was not blinded to participants or personnel and it is unclear whether the outcome assessors were also blinded. However, this is unlikely to affect the primary outcome, HIV incidence, as this is a biological measure. Losses due to the reason "other" were also recorded more in the intervention group (11.0% versus 5.0%). There was a lack of comparability between the treatment and comparison communities, probably due to the small sample size (N = 12). Contamination effects were also noted by the authors.</P>
<P>
<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>: Allocation sequence generation is unclear. Although the authors state that paired communities were randomised, it is unclear how this randomisation was achieved. It is also unclear if the allocation sequence was concealed from those assigning the groups. Study was block randomised. Participants were blinded but personnel and outcome assessors were not. However, this is unlikely to affect the primary biological outcome. Incomplete outcome data were adequately addressed.Those who dropped out tended to be younger. Participants may have discerned their randomised assignment. The potential for biasing the results to the null because of STI services were also provided to the control group as ethically required. The study may have required longer duration of follow-up to detect differences in HIV incidence.</P>
<P>
<LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>: Allocation sequence generation is clear and adequate. Allocation sequence was concealed from those assigning the groups. Neither participants nor personnel were blinded but outcome assessors were. This is most likely adequate. Large numbers of potential participants refused to participate. The study was randomised by communities with matching done in triplets based on geographical characteristics. During the trial, authors noticed substantial secular changes towards safer sexual behaviour in the whole study population, unrelated to their interventions, either in response to the HIV-1 epidemic itself or to HIV-specific health education from governmental and non-governmental sources and in the media.The authors acknowledge that bias in the form of people reporting what they thought was the right answer could have occurred. The study was possibly underpowered.</P>
<P>
<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>: Allocation sequence generation is clear and adequate. Allocation sequence was concealed from those assigning the groups. There was no blinding of participants, personnel or outcome assessors but this likely would not affect the primary outcome of HIV incidence. Incomplete outcome data were adequately addressed. Although intervention contamination was minimised in the control groups by the authors, a similar peer-education program was implemented in one control community and HIV prevention activity was considerable in all control communities that also had greater access to information from external sources. Contamination may have limited the authors' ability to detect a meaningful reduction in HIV-1 incidence. Moreover, large numbers were lost to follow-up in both groups, although the percentages lost to follow-up were similar in both the intervention and comparison groups.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-02-16 21:58:32 -0800" MODIFIED_BY="[Empty name]">
<P>
<B>1. Incidence of HIV infection</B>
</P>
<P>
<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK> reported that the incidence of HIV infection in the intervention groups was 1.2% per 100 person years compared with 1.9% per 100 person years in the control groups; the adjusted risk ratio was 0.58 (95% CI 0.42-0.79). In a fully adjusted analysis this corresponded to a 42.0% reduction (95% CI 21.0% - 58.0% reduction) in HIV incidence in the intervention group.</P>
<P>
<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK> reported, after three rounds of mass treatment, the fully adjusted rate ratio of incident HIV infection in intervention versus control communities was 0.97 (95% CI 0.81 - 1.2), indicating no effect of the intervention.</P>
<P>
<LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK> reported, after three rounds of behavioural and STI interventions, the adjusted rate ratio of incident HIV infection in (behavioural and STI interventions) versus control communities was 1.00 (95% CI 0.63 - 1.6), indicating no effect of the intervention.</P>
<P>
<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK> reported that the adjusted incidence rate ratio for HIV was 1.3 (95% CI 0.92 - 1.8) for the intervention group, relative to the control group. However, males in the intervention group had lower HIV-1 incidence (incidence RR 0.48, 95% CI 0.24 - 0.98).</P>
<P>Our meta-analysis combining the four studies shows no evidence that biomedical STI interventions reduced the incidence of HIV. The risk ratio is 0.93, (95% CI 0.67 - 1.3), corresponding to a statistically insignificant 7% reduction in HIV incidence for those exposed to biomedical STI interventions. There is moderate heterogeneity between the studies, with an <I>I</I>
<SUP>2</SUP> of 51% (&#967;<SUP>2</SUP> = 6.2, df = 3, <I>P</I> = 0.10).</P>
<P>If we only look at the three studies (<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>, <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>, and <LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>) with improved STI management (rather than mass treatment), there is no evidence that such interventions reduce the incidence of HIV. The risk ratio is 0.88 (95% CI 0.52 - 1.5). There is high heterogeneity between the studies, with an <I>I</I>
<SUP>2</SUP> of 67% (&#967;<SUP>2</SUP> = 6.1, df = 2, <I>P</I> = 0.05).</P>
<P>
<B>2. Incidence and prevalence of STIs</B>
</P>
<P>
<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK> reported that there was no significant reduction in gonorrhoea, chlamydia, urethritis or reported symptoms between trial groups. The prevalence of serologically-diagnosed syphilis in the intervention community was 5% compared with 7% in the control community at the end of the trial (aRR 0.71, 95% CI 0.54 - 0.93). Prevalence of reported symptomatic urethritis was 1.6% in intervention and 2.5% in control communities (aRR 0.51, 95% CI 0.24 - 1.1).</P>
<P>
<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK> reported that there was no significant reduction in gonorrhoea, chlamydia, urethritis, or reported STI symptoms between trial groups. The prevalence ratio of syphilis between intervention and control groups at the end of the trial was 0.80 (95% CI 0.71 - 0.89), of trichomoniasis 0.59 (95% CI 0.38 - 0.91) and of bacterial vaginosis 0.87 (95% CI 0.74 - 1.02).</P>
<P>
<LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK> reported that there was a significant decrease in gonorrhoea and active syphilis. RRs respectively were 0.29 (95% CI 0.12 - 0.71) and 0.53 (95% CI 0.33 - 0.84). There was not a significant decrease in chlamydia prevalence; RR was 0.99 (95% CI 0.70 - 1.4). There was no difference in the aRR of herpes simplex type 2 virus; aRR was 1.02 (95% CI 0.69 - 1.5).</P>
<P>
<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK> reported that there was no significant difference for the incidence of self-reported STI symptoms between the intervention and comparison groups. However, more male STI patients in the intervention communities reported cessation of symptoms (OR 0.40, 95% CI 0.20 - 0.83).</P>
<P>Data were combined for only syphilis, gonorrhoea, and chlamydia prevalence for two studies (<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK> and <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>) as there were no laboratory-based STI outcomes in <LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>. Moreover, in <LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>, the outcomes for chlamydia and gonorrhoea were reported for men only. We find that there is a significant 12% reduction in the prevalence of syphilis for those receiving a biomedical STI intervention (RR 0.88, 95% CI 0.80 - 0.96), with low heterogeneity between the two studies (<I>I</I>
<SUP>2</SUP> = 12%, &#967;<SUP>2</SUP> = 1.1, df = 1, <I>P</I> = 0.29). For gonorrhoea, we found a statistically significant 51% reduction in its prevalence in those receiving any biomedical intervention (RR 0.49, 95% CI 0.31 - 0.77). There was low heterogeneity between the two studies (<I>I</I>
<SUP>2</SUP> = 0%, &#967;<SUP>2</SUP> = 0.60, df = 1, <I>P</I> = 0.44). Finally, for chlamydia, we found no significant difference between any biomedical intervention and control in the combination of the two studies (RR 1.03, 95% CI 0.77 - 1.4). There was low heterogeneity between the two studies (<I>I</I>
<SUP>2</SUP> = 0%, &#967;<SUP>2</SUP> = 0.13, df = 1, <I>P</I> = 0.72).</P>
<P>
<B>3. Safer sexual behaviour</B>
</P>
<P>
<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK> reported that there was no difference in condom use, reported lifetime number of sexual partners or number of partners during the past year between intervention and control communities either before or after the intervention.</P>
<P>
<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK> reported that there was no significant change in the variables used to measure safer sexual behaviour. At the end of the trial, 14% of residents of intervention communities and 11% of residents of control communities reported condom use in the preceding six months, and 5.5% vs. 4.1% reported consistent condom use with a primary partner.</P>
<P>
<LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK> reported that there was a trend towards a significant outcome for increase in condom use with last partner; RR was 1.3 (95% CI 0.83 - 1.8). Otherwise there were no significant changes for the other outcomes measured of reported genital ulcers, reported urethral discharge or reported vaginal discharge.</P>
<P>
<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK> reported that there were no significant differences between the intervention group and the control group with respect to high-risk sexual behaviours. However, fewer men who were in the intervention group reported unprotected sex with casual partners (OR 0.45, 95% CI 0.28 - 0.75).</P>
<P>In combining three studies (<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>, <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>, and <LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>), we find that there is a significant 18.0% increase in the rate of regular condom use in those exposed to any biomedical intervention (RR 1.2, 95% CI 1.04 - 1.3) compared to control. There was high heterogeneity among the studies (<I>I</I>
<SUP>2</SUP> = 80%, &#967;<SUP>2</SUP> = 10.2, df = 2, <I>P</I> &lt; 0.006). Combining all four studies, we find that there is a small, but significant 7% increase in the percentage of people who had two or more sexual partners in the past year (RR 1.1, 95% CI 1.01 - 1.1). There is low heterogeneity among the four studies (<I>I</I>
<SUP>2</SUP> = 0%, &#967;<SUP>2</SUP> = 0.38, df = 3, <I>P</I> = 0.94).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-02-16 22:17:11 -0800" MODIFIED_BY="[Empty name]">
<P>The preponderance of the evidence from community-based randomised controlled trials suggests that biomedical STI control interventions are not an effective HIV prevention strategy. Only one study (<LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>) found a protective effect; the other three (<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>, <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>, and <LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>) failed to find a significant protective effect. In meta-analysis we found that there was no statistically significant effect of the four studies overall or when subdividing them into STI control program interventions and mass treatment interventions. An intriguing finding in Gregson is that there was a statistically significant decrease in HIV incidence in men only. None of the other studies analysed HIV incidence by gender so meta-analysis was not possible. Nevertheless, this finding might point to differential risk behaviour modification between the sexes.</P>
<P>In the previous review (<LINK REF="REF-Sangani-2004" TYPE="REFERENCE">Sangani 2004</LINK>), we had identified five studies for inclusion. For this update, we expanded our search strategy (see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) and refined our inclusion and exclusion criteria. Specifically, we stipulated that studies must include HIV incidence as an endpoint. We also focused on biomedical interventions in general populations and excluded studies based on behavioural interventions. As a result, we included one new study that had been published since the last review (<LINK REF="STD-Gregson-2007" TYPE="STUDY">Gregson 2007</LINK>), and excluded two studies (<LINK REF="STD-Garcia-1998" TYPE="STUDY">Garcia 1998</LINK> and <LINK REF="STD-Mayaud-1997" TYPE="STUDY">Mayaud 1997</LINK>) that were originally in the 2004 review.</P>
<P>Other studies examining sub-populations have been published. One such study by Basu et al (<LINK REF="STD-Basu-2004" TYPE="STUDY">Basu 2004</LINK>) studied sex workers in India. A community-level intervention was thought to be responsible for the low prevalence of HIV in Calcutta, due to high condom use. Although HIV incidence was not an outcome, Basu et al showed that the community-level intervention resulted in significantly higher rates of condom usage when compared to the control group. Reza-Paul et al (<LINK REF="STD-Reza_x002d_Paul-2008" TYPE="STUDY">Reza-Paul 2008</LINK>) also published a study examining female sex workers in India. Two cross-sectional studies done on condom usage after a community-led HIV preventive intervention showed increased condom usage after the intervention as compared to before.</P>
<P>The difference in outcomes for chlamydia and gonorrhoea are puzzling. We postulate that this may be due to different sub-populations being affected by chlamydia and gonorrhoea.</P>
<P>It should be noted that we did not account for adjustment of possible confounders by the authors. Bias may be present in our review because of this. However, because most of the adjusted and unadjusted effect measures reported by the original authors did not differ by much, the bias is likely very minimal. Another source of potential bias may be the use of the ICCs. The calculations reported in <LINK REF="REF-Todd-2003" TYPE="REFERENCE">Todd 2003</LINK> used "baseline HIV prevalence" as a proxy in calculating the ICCs. As a result, the actual ICCs may differ. However, the resulting difference would only affect the 95% CIs and would likely be minimal. In combining the studies there were moderate-substantial amounts of heterogeneity. Due to the fact that so few studies were included in the meta-analysis, investigation of heterogeneity was not done and likely not necessary (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>).</P>
<P>Despite the evidence showing that STI interventions can change behaviour, our review shows that such interventions have no effect on population-level HIV incidence. The differing results of the Grosskurth and Wawer trials were initially perplexing. In the 2004 review, with the addition of the data from <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>, which studied a population similar to that of Wawer, the conclusion that STI interventions have little to no effect on HIV incidence in communities where the HIV epidemic is stabilised was strengthened. The Gregson trial, done in eastern Zimbabwe where the HIV prevalence was over 20%, further strengthens the argument that STI interventions have minimal population effect on HIV incidence where HIV has become endemic. This makes sense biologically. In a rising epidemic, there are many discordant sexual relationships. Having a concurrent STI will increase one's risk of acquiring HIV infection in a discordant sexual relationship. However, in a population in which HIV prevalence remains largely constant, most sexual relationships are likely concordant and thus, on a population basis, treating STIs will have little effect on HIV transmission.</P>
<P>There is evidence for the impact of the STI control interventions tested in three trials (<LINK REF="STD-Wawer-1999" TYPE="STUDY">Wawer 1999</LINK>, <LINK REF="STD-Grosskurth-1995" TYPE="STUDY">Grosskurth 1995</LINK>, and <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>) on the incidence and prevalence of STIs. In both the Wawer and Kamali trials, rates of syphilis fell significantly, as did rates of trichomoniasis. Furthermore, <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK> observed significant reduction in the rates of gonorrhoea. Additionally, our meta-analysis of two studies shows that there are significant decreases in prevalence of syphilis, gonorrhoea, and trichomoniasis. However, there was no significant decrease in the prevalence of chlamydia.</P>
<P>The Grosskurth and Wawer trials have limited data available to allow an exploration of proximal factors that may be important in the chain of causality. For example, there are some (but incomplete) data on STI prevalence and incidence, and there are few data on health-seeking behaviour and quality of care in these settings</P>
<P>The Grosskurth trial noted non-significant decreases in prevalence of active syphilis, chlamydia, gonorrhoea, and urethritis in the intervention group versus the control group. This was not included in the meta-analysis as these results were limited to men only. The Wawer trial consisted of an intervention that had mass treatment only, regardless of STI symptoms, whereas the Kamali trial had three groups: one exposed to the behavioural intervention only (Group A). a second to the behavioural intervention and improved syndromic management of STIs (Group B); and a third control group to government services only (Group C). Unfortunately, because of small numbers, the prevalence ratios and the associated 95% CIs are not reliable for gonorrhoea and chlamydia infections in the Wawer trial. The Kamali trial demonstrates that the improved STI syndromic management component of their intervention is responsible for decreased gonorrhoea prevalence; the aRR for Group A versus Group C for gonorrhoea prevalence is 0.74 (95% CI 0.30 - 1.8), that for Group B versus Group C is 0.28 (95% CI 0.11 - 0.70). Interestingly, the prevalence of chlamydia was higher in Group B than in Group A, even though Group B had both the behavioural and STI syndromic management interventions. This may be due to higher baseline prevalence of chlamydia in Group B; this, however, was not presented in the trial. The Wawer trial, which was the only trial to provide mass treatment of antibiotics to participants in the intervention arm found a non-significant decrease in the prevalence of chlamydia.</P>
<P>Why did the Grosskurth and Wawer trials, both testing a community-based STI control strategy, deliver apparently contradictory results? First, the two trials were actually testing quite different interventions: strengthened primary care STI syndromic management in Grosskurth and rounds of mass community treatment, irrespective of symptoms, in Wawer. Secondly, as noted above, the HIV epidemic in the two settings was quite different, with the HIV epidemic in Uganda relatively more mature than the evolving epidemic in Tanzania. In a setting like Uganda where HIV prevalence was quite high (16%) and had spread beyond high risk groups into the more general population, the role of STIs in HIV spread is reduced and hence the role of STI control in HIV control will be somewhat less important. In fact, in a sub-analysis of the Wawer data, the population attributable fraction for STI in HIV transmission was only 10% (<LINK REF="REF-Hudson-2001" TYPE="REFERENCE">Hudson 2001</LINK>, <LINK REF="REF-Hayes_x002c_-1997" TYPE="REFERENCE">Hayes, 1997</LINK>). This could be because in more mature epidemics the bulk of transmission occurs between serodiscordant couples in which the HIV-uninfected partner is repeatedly exposed (<LINK REF="REF-Hudson-2001" TYPE="REFERENCE">Hudson 2001</LINK>, <LINK REF="REF-Gray-1999" TYPE="REFERENCE">Gray 1999</LINK>). This population attributable fraction will only be lower with the provision of antiretroviral therapy (<LINK REF="REF-Bunnell-2006" TYPE="REFERENCE">Bunnell 2006</LINK>). It is also important to consider the role of herpes simplex type 2 infections in HIV transmission. There have been consistent data showing that HSV and HIV infections are associated (<LINK REF="REF-Malkin-2004" TYPE="REFERENCE">Malkin 2004</LINK>). However, there have been conflicting results from trials looking at HSV suppression on the incidence of HIV infection. One study (<LINK REF="REF-Nagot-2007" TYPE="REFERENCE">Nagot 2007</LINK>) showed a significant decrease in plasma and genital HIV-1 RNA levels. However, two other large-scale randomised controlled trials (<LINK REF="REF-Watson_x002d_Jones-2008" TYPE="REFERENCE">Watson-Jones 2008</LINK> and <LINK REF="REF-Celum-2010" TYPE="REFERENCE">Celum 2010</LINK>) showed no evidence that herpes suppression decreases the risk of HIV infection. Also, it is possible that symptomatic STIs (targeted in Grosskurth) are relatively more important as facilitators of HIV spread compared with asymptomatic STIs (targeted in Wawer), due to the increased inflammatory response associated with them. Furthermore, in Wawer's study, STI may have been reintroduced more easily than in Grosskurth because of the lack of high quality, continuously available treatment services (<LINK REF="REF-Grosskurth-2000" TYPE="REFERENCE">Grosskurth 2000</LINK>).</P>
<P>The addition of the Gregson trial provides more evidence that there is minimal effect, if any, of STI syndromic management (including counselling services) on decreasing the proportion of people who have had two or more casual partners in the past year. However, it is encouraging that regular condom use increased, with the addition of the Gregson trial, in concert with what was found previously by <LINK REF="STD-Kamali-2003" TYPE="STUDY">Kamali 2003</LINK>.</P>
<P>Trials reported no adverse events except for a small increase in the proportion of people in the intervention arms that reported two or more casual sexual partners in the prior year (RR 1.1, 95% CI 1.01 - 1.1). This increase was seen in all four studies, and the magnitude of the effects was similar, as indicated by the low heterogeneity. Only the Wawer study was able to blind participants to which arm they were in; thus, patients in the intervention arms may have been more prone to increased sexual risk taking. An alternative explanation might be that the lower bound of the 95% CI may actually extend below 1 due to the fact that we did not use the effective sample size in our calculations, as the ICCs were not available for secondary outcomes. There were no other differences in sexual behaviour that were found in the meta analyses of the studies.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-02-16 22:11:28 -0800" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-02-16 22:10:51 -0800" MODIFIED_BY="[Empty name]">
<P>The preponderance of evidence from community randomised controlled trials suggests that biomedical STI control interventions are not an efficacious HIV prevention strategy, and there is no evidence of efficacy in populations where HIV incidence is not rising rapidly. The addition of the Gregson trial further supports this conclusion. Improved STI treatment services have been shown to reduce HIV incidence in only one trial and in a particular environment characterised by an emerging HIV epidemic (low and slowly rising prevalence), where STI treatment services were poor and STIs highly prevalent. There is no evidence for benefit from mass treatment of communities, at least for the regimen tested in Wawer. There are, however, other compelling reasons why STI treatment services should be strengthened, and the evidence from these studies demonstrates that when a health service intervention is effectively implemented, it can substantially improve quality of STI service provision, at least in the short term, and lead to decreased prevalence of some STIs.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-02-16 22:11:28 -0800" MODIFIED_BY="[Empty name]">
<P>With three negative trials, it is unlikely that future trials will focus on improved STI management to decrease the incidence of HIV. Future trials of biomedical interventions that involve individual randomisation, however, may represent an opportunity to reexamine presumptive treatment of STIs. Such trials should also aim to measure a range of factors that include health-seeking behaviour and quality of treatment, as well as HIV, STI and other biological endpoints.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-02-14 14:21:14 -0800" MODIFIED_BY="Tara Horvath">
<P>We thank Ms. Joy Oliver of the South African Cochrane Centre for conducting database searches at an earlier stage of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2011-02-14 14:34:20 -0800" MODIFIED_BY="Tara Horvath">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2011-02-16 11:02:43 -0800" MODIFIED_BY="Tara Horvath">
<UL>
<LI>B Ng: screening search results, screening retrieved papers against eligibility criteria, appraising quality of papers, extracting data from papers, entering data into RevMan, analysis of data, writing the review</LI>
<LI>LM Butler: screening search results, screening retrieved papers against eligibility criteria, appraising quality of papers, extracting data from papers, interpretation of data, writing the review</LI>
<LI>T Horvath: coordinating the review, designing and implementing search strategies, screening search results, organising retrieval of papers, providing general advice on the review</LI>
<LI>GW Rutherford: designing the review, interpretation of data, providing general advice on the review, securing funding for the review</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-02-14 15:27:51 -0800" MODIFIED_BY="Tara Horvath">
<P>The original protocol for this review (<LINK REF="REF-Wilkinson-1998" TYPE="REFERENCE">Wilkinson 1998</LINK>) provided these criteria for types of interventions under consideration:</P>
<UL>
<LI>
<I>Any population-level STD intervention including, but not exclusive to: 1) information, education and communication campaigns aimed at promoting safer sexual behaviour, increased condom use, and better STD treatment seeking behaviour, 2) improved STD treatment services, 3) integration of STD case finding into family planning, antenatal care and other health services, and 4) mass treatment of whole communities </I>
</LI>
</UL>
<P>The first published version of the full review (<LINK REF="REF-Wilkinson-2001" TYPE="REFERENCE">Wilkinson 2001</LINK>) and the review's first update (<LINK REF="REF-Sangani-2004" TYPE="REFERENCE">Sangani 2004</LINK>) considered including these kinds of interventions.</P>
<P>In the present update, we focused on biomedical interventions in general populations and excluded studies based on behavioural interventions. We also stipulated that studies must include HIV incidence as an endpoint.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath">
<STUDIES MODIFIED="2011-02-16 15:51:54 -0800" MODIFIED_BY="Tara Horvath">
<INCLUDED_STUDIES MODIFIED="2010-08-26 13:53:32 -0700" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gregson-2007" MODIFIED="2010-08-25 14:33:25 -0700" MODIFIED_BY="[Empty name]" NAME="Gregson 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-08-09 16:00:24 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, Garnett GP, Chandiwana SK, Foster G, Anderson RM</AU>
<TI>Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe</TI>
<SO>PLoS Medicine</SO>
<YR>2007</YR>
<VL>4</VL>
<NO>3</NO>
<PG>545-555</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grosskurth-1995" MODIFIED="2010-08-25 14:33:03 -0700" MODIFIED_BY="[Empty name]" NAME="Grosskurth 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, Newell J, Mugeye K, Mabey D, Hayes R.</AU>
<TI>Imapct of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>346</VL>
<PG>530-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamali-2003" MODIFIED="2010-08-26 13:53:32 -0700" MODIFIED_BY="[Empty name]" NAME="Kamali 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-08-26 13:53:32 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamali A,Quigley M, et al</AU>
<TI>Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial</TI>
<SO>Lancet</SO>
<YR>2003</YR>
<VL>vol 361</VL>
<PG>645-652</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wawer-1999" MODIFIED="2010-08-25 14:33:36 -0700" MODIFIED_BY="[Empty name]" NAME="Wawer 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, Wabwire-Mangen F, Li C, lutalo T, Nalugoda F, Gaydos CA, Moulton LH, Meehan MO, Ahmed S, the Rakai Project Study Group and Gray RH</AU>
<TI>Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>353</VL>
<NO>9152</NO>
<PG>525-535</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-02-16 15:51:54 -0800" MODIFIED_BY="Tara Horvath">
<STUDY DATA_SOURCE="PUB" ID="STD-Asamoah_x002d_Adu-1994" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Asamoah-Adu 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Asamoah-Adu A, Weir S, Pappoe M, Kanlisi N, Neequaye A, Lamptey P</AU>
<TI>Evaluation of a targeted AIDS prevention intervention to increase condom use among prostitutes in Ghana</TI>
<SO>AIDS (London, England)</SO>
<YR>1994</YR>
<VL>8</VL>
<NO>2</NO>
<PG>239-46</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8043229"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Basu-2004" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Basu 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Basu I, Jana S, Rotheram-Borus MJ, Swendeman D, Lee SJ, Newman P, et al</AU>
<TI>HIV prevention among sex workers in India</TI>
<SO>Journal of acquired immune deficiency syndromes (1999)</SO>
<YR>2004</YR>
<VL>36</VL>
<NO>3</NO>
<PG>845-52</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15213569"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-CDC-1999" MODIFIED="2010-08-17 15:12:49 -0700" MODIFIED_BY="[Empty name]" NAME="CDC 1999" YEAR="1999">
<REFERENCE MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<TI>Community-level HIV intervention in 5 cities: final outcome data from the CDC AIDS Community Demonstration Projects</TI>
<SO>American journal of public health</SO>
<YR>1999</YR>
<VL>89</VL>
<NO>3</NO>
<PG>336-45</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10076482"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clark-1998" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Clark 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clark LR, Brasseux C, Richmond D, Getson P, D'Angelo LJ</AU>
<TI>Effect of HIV counseling and testing on sexually transmitted diseases and condom use in an urban adolescent population</TI>
<SO>Archives of pediatrics &amp; adolescent medicine</SO>
<YR>1998</YR>
<VL>152</VL>
<NO>3</NO>
<PG>269-73</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9529465"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coates-2000" MODIFIED="2010-08-17 15:07:46 -0700" MODIFIED_BY="[Empty name]" NAME="Coates 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<TI>Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>356</VL>
<NO>9224</NO>
<PG>103-12</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10963246"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cowan-2008" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Cowan 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cowan FM, Pascoe SJ, Langhaug LF, Dirawo J, Chidiya S, Jaffar S, et al</AU>
<TI>The Regai Dzive Shiri Project: a cluster randomised controlled trial to determine the effectiveness of a multi-component community-based HIV prevention intervention for rural youth in Zimbabwe--study design and baseline results</TI>
<SO>Tropical medicine &amp; international health : TM &amp; IH</SO>
<YR>2008</YR>
<VL>13</VL>
<NO>10</NO>
<PG>1235-44</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18778329"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deren-1995" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Deren 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deren S, Davis WR, Beardsley M, Tortu S, Clatts M</AU>
<TI>Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS project</TI>
<SO>AIDS education and prevention : official publication of the International Society for AIDS Education</SO>
<YR>1995</YR>
<VL>7</VL>
<NO>5</NO>
<PG>379-90</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8672391"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doyle-2010" MODIFIED="2010-08-26 13:53:58 -0700" MODIFIED_BY="[Empty name]" NAME="Doyle 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-08-26 13:53:58 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doyle AM, Ross DA, Maganja K, Baisley K, Masesa C, Andreasen A, et al</AU>
<TI>Long-term biological and behavioural impact of an adolescent sexual health intervention in Tanzania: follow-up survey of the community-based MEMA kwa Vijana Trial</TI>
<SO>PLoS medicine</SO>
<YR>2010</YR>
<VL>7</VL>
<NO>6</NO>
<PG>e1000287</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20543994"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feldblum-2001" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Feldblum 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feldblum PJ, Kuyoh MA, Bwayo JJ, Omari M, Wong EL, Tweedy KG, et al</AU>
<TI>Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya</TI>
<SO>AIDS (London, England)</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>8</NO>
<PG>1037-44</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11399986"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Figueiredo-2002" MODIFIED="2010-08-26 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Figueiredo 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-08-26 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Figueiredo R, Ayres JR</AU>
<TI>Community based intervention and reduction of women's vulnerability to STD/AIDS in Brazil</TI>
<TO>Intervenção comunitária e redução da vulnerabilidade de mulheres as DST/ Aids em Sao Paulo, SP.</TO>
<SO>Revista de Saude Pública</SO>
<YR>2002</YR>
<VL>36</VL>
<NO>4 Suppl</NO>
<PG>96-107</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12364906"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Figueroa-2010" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Figueroa 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Figueroa JP, Weir SS, Byfield L, Hall A, Cummings SM, Suchindran CM</AU>
<TI>The challenge of promoting safe sex at sites where persons meet new sex partners in Jamaica: results of the Kingston PLACE randomized controlled trial</TI>
<SO>Tropical medicine &amp; international health : TM &amp; IH</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>8</NO>
<PG>945-54</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20545916"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia-1998" MODIFIED="2010-08-18 14:03:07 -0700" MODIFIED_BY="[Empty name]" NAME="Garcia 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-08-18 14:03:05 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia PJ, Gotuzzo E, Hughes JP, Holmes KK</AU>
<TI>Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial</TI>
<SO>Sex Transm Inf</SO>
<YR>1998</YR>
<VL>74</VL>
<NO>Suppl 1</NO>
<PG>S153-S158</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia-2003" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Garcia 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia P, Hughes J, Carcamo C, Holmes KK</AU>
<TI>Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2003</YR>
<VL>81</VL>
<NO>11</NO>
<PG>806-14</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14758407"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Golub-2000" MODIFIED="2010-08-17 15:43:13 -0700" MODIFIED_BY="[Empty name]" NAME="Golub 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 15:43:12 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gollub EL, French P, Loundou A, Latka M, Rogers C, Stein Z.</AU>
<TI>A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women</TI>
<SO>AIDS</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>1249-1255</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grosskurth-2000" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Grosskurth 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grosskurth H, Mwijarubi E, Todd J, Rwakatare M, Orroth K, Mayaud P, et al</AU>
<TI>Operational performance of an STD control programme in Mwanza Region, Tanzania</TI>
<SO>Sexually transmitted infections</SO>
<YR>2000</YR>
<VL>76</VL>
<NO>6</NO>
<PG>426-36</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11221123"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harvey-2000" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Harvey 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Harvey B, Stuart J, Swan T</AU>
<TI>Evaluation of a drama-in-education programme to increase AIDS awareness in South African high schools: a randomized community intervention trial</TI>
<SO>International journal of STD &amp; AIDS</SO>
<YR>2000</YR>
<VL>11</VL>
<NO>2</NO>
<PG>105-11</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10678478"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayes-1995" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Hayes 1995" YEAR="1995">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayes R, Mosha F, Nicoll A, Grosskurth H, Newell J, Todd J, et al</AU>
<TI>A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design</TI>
<SO>AIDS (London, England)</SO>
<YR>1995</YR>
<VL>9</VL>
<NO>8</NO>
<PG>919-26</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7576328"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hayes-2005" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Hayes 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hayes RJ, Changalucha J, Ross DA, Gavyole A, Todd J, Obasi AI, et al</AU>
<TI>The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania</TI>
<SO>Contemporary clinical trials</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>4</NO>
<PG>430-42</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15951245"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hudson-2001" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Hudson 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hudson CP</AU>
<TI>Community-based trials of sexually transmitted disease treatment: repercussions for epidemiology and HIV prevention</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2001</YR>
<VL>79</VL>
<NO>1</NO>
<PG>48-58</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11217667"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jana-2004" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Jana 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jana S, Basu I, Rotheram-Borus MJ, Newman PA</AU>
<TI>The Sonagachi Project: a sustainable community intervention program</TI>
<SO>AIDS education and prevention : official publication of the International Society for AIDS Education</SO>
<YR>2004</YR>
<VL>16</VL>
<NO>5</NO>
<PG>405-14</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15491952"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamb-1998" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Kamb 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al</AU>
<TI>Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group</TI>
<SO>JAMA : the journal of the American Medical Association</SO>
<YR>1998</YR>
<VL>280</VL>
<NO>13</NO>
<PG>1161-7</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9777816"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kegeles-1996" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Kegeles 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kegeles SM, Hays RB, Coates TJ</AU>
<TI>The Mpowerment Project: a community-level HIV prevention intervention for young gay men</TI>
<SO>American journal of public health</SO>
<YR>1996</YR>
<VL>86</VL>
<NO>8</NO>
<PG>1129-36</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8712273"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelly-1997" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Kelly 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelly JA, Murphy DA, Sikkema KJ, McAuliffe TL, Roffman RA, Solomon LJ, et al</AU>
<TI>Randomised, controlled, community-level HIV-prevention intervention for sexual-risk behaviour among homosexual men in US cities. Community HIV Prevention Research Collaborative</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>350</VL>
<NO>9090</NO>
<PG>1500-5</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9388397"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lauby-2000" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Lauby 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lauby JL, Smith PJ, Stark M, Person B, Adams J</AU>
<TI>A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects</TI>
<SO>American journal of public health</SO>
<YR>2000</YR>
<VL>90</VL>
<NO>2</NO>
<PG>216-22</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10667182"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maher-2003" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Maher 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maher JE, Peterman TA, Osewe PL, Odusanya S, Scerba JR</AU>
<TI>Evaluation of a community-based organization's intervention to reduce the incidence of sexually transmitted diseases: a randomized, controlled trial</TI>
<SO>Southern medical journal</SO>
<YR>2003</YR>
<VL>96</VL>
<NO>3</NO>
<PG>248-53</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12661534"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayaud-1997" MODIFIED="2010-08-18 14:05:28 -0700" MODIFIED_BY="[Empty name]" NAME="Mayaud 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-08-18 14:05:25 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayaud P, Mosha F, Todd J, Balira R, Mgara J, West B, Rusizoka M, Mwijarubi E, Gabone R, Gavyole A, Grosskurth H, Hayes R, Mabey D</AU>
<TI>Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomised controlled trial</TI>
<SO>AIDS</SO>
<YR>1997</YR>
<VL>11</VL>
<PG>1873-1880</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MMWR-1996" MODIFIED="2010-08-17 15:11:02 -0700" MODIFIED_BY="[Empty name]" NAME="MMWR 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<TI>Community-level prevention of human immunodeficiency virus infection among high-risk populations: the AIDS Community Demonstration Projects</TI>
<SO>MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control</SO>
<YR>1996</YR>
<VL>45</VL>
<NO>RR-6</NO>
<PG>1-24</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8606680"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NIMH-1998" MODIFIED="2010-08-17 15:10:07 -0700" MODIFIED_BY="[Empty name]" NAME="NIMH 1998" YEAR="1998">
<REFERENCE MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<TI>The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group</TI>
<SO>Science (New York, N.Y.)</SO>
<YR>1998</YR>
<VL>280</VL>
<NO>5371</NO>
<PG>1889-94</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9632382"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NIMH-2010" MODIFIED="2011-02-16 10:51:45 -0800" MODIFIED_BY="Tara Horvath" NAME="NIMH 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<TI>Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention</TI>
<SO>Journal of acquired immune deficiency syndromes (1999)</SO>
<YR>2010</YR>
<VL>54</VL>
<NO>2</NO>
<PG>204-14</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20354444"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-02-16 10:51:45 -0800" MODIFIED_BY="Tara Horvath"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pronyk-2006" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Pronyk 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pronyk PM, Hargreaves JR, Kim JC, Morison LA, Phetla G, Watts C, et al</AU>
<TI>Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial</TI>
<SO>Lancet</SO>
<YR>2006</YR>
<VL>368</VL>
<NO>9551</NO>
<PG>1973-83</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="17141704"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pronyk-2008" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Pronyk 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pronyk PM, Kim JC, Abramsky T, Phetla G, Hargreaves JR, Morison LA, et al</AU>
<TI>A combined microfinance and training intervention can reduce HIV risk behaviour in young female participants</TI>
<SO>AIDS (London, England)</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>13</NO>
<PG>1659-65</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18670227"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pronyk-2008a" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Pronyk 2008a" YEAR="2008">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pronyk PM, Harpham T, Busza J, Phetla G, Morison LA, Hargreaves JR, et al</AU>
<TI>Can social capital be intentionally generated? a randomized trial from rural South Africa</TI>
<SO>Social science &amp; medicine (1982)</SO>
<YR>2008</YR>
<VL>67</VL>
<NO>10</NO>
<PG>1559-70</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18771833"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quigley-1997" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Quigley 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quigley M, Munguti K, Grosskurth H, Todd J, Mosha F, Senkoro K, et al</AU>
<TI>Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study</TI>
<SO>AIDS (London, England)</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>2</NO>
<PG>237-48</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9030372"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ramesh-2010" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Ramesh 2010" YEAR="2010">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ramesh BM, Beattie TS, Shajy I, Washington R, Jagannathan L, Reza-Paul S, et al</AU>
<TI>Changes in risk behaviours and prevalence of sexually transmitted infections following HIV preventive interventions among female sex workers in five districts in Karnataka state, south India</TI>
<SO>Sexually transmitted infections</SO>
<YR>2010</YR>
<VL>86 Suppl 1</VL>
<PG>i17-24</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="20167725"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reza_x002d_Paul-2008" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Reza-Paul 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reza-Paul S, Beattie T, Syed HU, Venukumar KT, Venugopal MS, Fathima MP, et al</AU>
<TI>Declines in risk behaviour and sexually transmitted infection prevalence following a community-led HIV preventive intervention among female sex workers in Mysore, India</TI>
<SO>AIDS (London, England)</SO>
<YR>2008</YR>
<VL>22 Suppl 5</VL>
<PG>S91-100</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="19098483"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robinson-2002" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Robinson 2002" YEAR="2002">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robinson BB, Uhl G, Miner M, Bockting WO, Scheltema KE, Rosser BR, et al</AU>
<TI>Evaluation of a sexual health approach to prevent HIV among low income, urban, primarily African American women: results of a randomized controlled trial</TI>
<SO>AIDS education and prevention : official publication of the International Society for AIDS Education</SO>
<YR>2002</YR>
<VL>14</VL>
<NO>3 Suppl A</NO>
<PG>81-96</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12092940"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sieverding-2005" MODIFIED="2010-08-17 15:46:50 -0700" MODIFIED_BY="[Empty name]" NAME="Sieverding 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-08-17 15:46:50 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sieverding J, Boyer CB, Siller J, Gallaread A, Krone M, Chang YJ</AU>
<TI>Youth united through health education: building capacity through a community collaborative intervention to prevent HIV/STD in adolescents residing in a high STD prevalent neighborhood</TI>
<SO>AIDS education and prevention : official publication of the International Society for AIDS Education</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>4</NO>
<PG>375-85</PG>
<IDENTIFIERS MODIFIED="2010-08-17 15:46:49 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="16178706"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sikkema-2000" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Sikkema 2000" YEAR="2000">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sikkema KJ, Kelly JA, Winett RA, Solomon LJ, Cargill VA, Roffman RA, et al</AU>
<TI>Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments</TI>
<SO>American journal of public health</SO>
<YR>2000</YR>
<VL>90</VL>
<NO>1</NO>
<PG>57-63</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10630138"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-St.-Lawrence-2001" MODIFIED="2010-08-17 13:56:40 -0700" MODIFIED_BY="[Empty name]" NAME="St. Lawrence 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>St Lawrence JS, Wilson TE, Eldridge GD, Brasfield TL, O'Bannon RE 3rd</AU>
<TI>Community-based interventions to reduce low income, African American women's risk of sexually transmitted diseases: a randomized controlled trial of three theoretical models</TI>
<SO>American journal of community psychology</SO>
<YR>2001</YR>
<VL>29</VL>
<NO>6</NO>
<PG>937-64</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11800513"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sun-2001" MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" NAME="Sun 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-08-17 14:45:02 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sun X, Huang C, Wen Y</AU>
<TI>A community-based acquired immunodeficiency syndrome education intervention study in Kunshan county</TI>
<SO>Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi</SO>
<YR>2001</YR>
<VL>22</VL>
<NO>5</NO>
<PG>326-9</PG>
<IDENTIFIERS MODIFIED="2010-08-17 14:44:57 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11769683"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2005" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Wang 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang DB, Zhang XJ, Zhang HB, Zhang CY, Su B</AU>
<TI>A rapid assessment of community-wide HIV/STI intervention in China</TI>
<SO>Sexually transmitted infections</SO>
<YR>2005</YR>
<VL>81</VL>
<NO>1</NO>
<PG>47-52</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="15681723"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2003" MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" NAME="Williams 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-08-17 13:55:38 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams BG, Taljaard D, Campbell CM, Gouws E, Ndhlovu L, Van Dam J, et al</AU>
<TI>Changing patterns of knowledge, reported behaviour and sexually transmitted infections in a South African gold mining community</TI>
<SO>AIDS (London, England)</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>14</NO>
<PG>2099-107</PG>
<IDENTIFIERS MODIFIED="2010-08-17 13:55:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="14502013"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath">
<ADDITIONAL_REFERENCES MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath">
<REFERENCE ID="REF-Abdool-Karim-2010" MODIFIED="2010-08-26 13:56:30 -0700" MODIFIED_BY="[Empty name]" NAME="Abdool Karim 2010" TYPE="JOURNAL_ARTICLE">
<AU>Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany ABM, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L,Taylor D</AU>
<TI>Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women</TI>
<SO>Sciencexpress</SO>
<YR>July 2010</YR>
<PG>1-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Attia-2009" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Attia 2009" TYPE="JOURNAL_ARTICLE">
<AU>Attia S</AU>
<TI>Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis</TI>
<SO>AIDS</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>11</NO>
<PG>1397-1404</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Auvert-2005" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Auvert 2005" TYPE="JOURNAL_ARTICLE">
<AU>Auvert, B, Taljaard, D, Lagarde, E, et al</AU>
<TI>Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial</TI>
<SO>PLoS Med</SO>
<YR>2005</YR>
<VL>2</VL>
<PG>e298</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bailey-2007" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Bailey 2007" TYPE="JOURNAL_ARTICLE">
<AU>Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO</AU>
<TI>Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial</TI>
<SO>Lancet</SO>
<YR>2007</YR>
<VL>369</VL>
<NO>9562</NO>
<PG>643-656</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bunnell-2006" MODIFIED="2010-08-20 13:03:06 -0700" MODIFIED_BY="[Empty name]" NAME="Bunnell 2006" TYPE="JOURNAL_ARTICLE">
<AU>Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, Coutinho A, Liechty C, Madraa E, Rutherford G, Mermin J</AU>
<TI>Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda</TI>
<SO>AIDS</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>1</NO>
<PG>85-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cameron-1989" NAME="Cameron 1989" TYPE="JOURNAL_ARTICLE">
<AU>Cameron DW, Simonsen JN, D'Costa LJ, Ronald AR, Maitha GM, Gakinya MN, et al</AU>
<TI>Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>ii</VL>
<PG>184-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Celum-2010" MODIFIED="2010-08-26 13:35:25 -0700" MODIFIED_BY="[Empty name]" NAME="Celum 2010" TYPE="JOURNAL_ARTICLE">
<AU>Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, et al</AU>
<TI>Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2</TI>
<SO>N Engl J Med</SO>
<YR>2010</YR>
<VL>362</VL>
<PG>427-439</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1997" NAME="Cohen 1997" TYPE="JOURNAL_ARTICLE">
<AU>Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Costello Daly C, et al</AU>
<TI>Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>349</VL>
<PG>1868-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Das-2010" MODIFIED="2010-08-19 14:38:38 -0700" MODIFIED_BY="[Empty name]" NAME="Das 2010" TYPE="JOURNAL_ARTICLE">
<AU>Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland V, Colfax GN</AU>
<TI>Decreases in Community Viral Load Are Accompanied byReductions in New HIV Infections in San Francisco</TI>
<SO>PLoS ONE</SO>
<YR>2010</YR>
<VL>5</VL>
<NO>6</NO>
<PG>1-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davis-1999" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Davis 1999" TYPE="JOURNAL_ARTICLE">
<AU>Davis KR, Weller SC</AU>
<TI>The effectiveness of condoms in reducing heterosexual transmission of HIV</TI>
<SO>Fam Plann Perspect</SO>
<YR>1999 Nov-Dec</YR>
<VL>31</VL>
<NO>6</NO>
<PG>272-279</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DCPP-2007" MODIFIED="2010-08-19 11:52:16 -0700" MODIFIED_BY="[Empty name]" NAME="DCPP 2007" TYPE="JOURNAL_ARTICLE">
<AU>Disease Control Priorities Project</AU>
<TI>Sexually transmitted infections are preventable and treatable, but the full benefit depends on the local context</TI>
<SO>Disease Control Priorities Project</SO>
<YR>2007</YR>
<PG>1-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fleming-1999" MODIFIED="2011-02-16 15:47:08 -0800" MODIFIED_BY="Tara Horvath" NAME="Fleming 1999" TYPE="JOURNAL_ARTICLE">
<AU>Fleming DT, Wasserheit JN</AU>
<TI>From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection</TI>
<SO>Sex Transm Infect</SO>
<YR>1999</YR>
<VL>75</VL>
<PG>3-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gray-1999" MODIFIED="2010-08-26 13:58:10 -0700" MODIFIED_BY="[Empty name]" NAME="Gray 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gray, et al.</AU>
<TI>Relative risks and population attributable fraction of incident HIV associated with symptoms and treatable STDs.</TI>
<SO>AIDS</SO>
<YR>1999</YR>
<VL>13</VL>
<PG>2113-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gray-2007" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Gray 2007" TYPE="JOURNAL_ARTICLE">
<AU>Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al</AU>
<TI>Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial</TI>
<SO>Lancet</SO>
<YR>2007</YR>
<VL>369</VL>
<NO>9562</NO>
<PG>657-666</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Grosskurth-2000" NAME="Grosskurth 2000" TYPE="JOURNAL_ARTICLE">
<AU>Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M</AU>
<TI>Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>355</VL>
<PG>1981-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hayes_x002c_-1997" NAME="Hayes, 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hayes, et al.</AU>
<TI>Randomized trials of STD treatment for HIV prevention</TI>
<SO>Genitourinary Med</SO>
<YR>1977</YR>
<VL>73</VL>
<PG>432-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2010-08-20 09:53:18 -0700" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Altman DG</AU>
<TI>Assessing risk of bias in included studies</TI>
<SO>Cochrane Handbook for Systematic Reviews of Interventions</SO>
<YR>2008</YR>
<ED>Higgins JPT, Green S</ED>
<PB>Wiley-Blackwell</PB>
<CY>West Sussex, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hudson-2001" NAME="Hudson 2001" TYPE="JOURNAL_ARTICLE">
<AU>Hudson CP</AU>
<TI>Community-based trials of sexually transmitted disease treatment: repercussions for epidemiology and HIV prevention.</TI>
<SO>Bull WHO</SO>
<YR>2001</YR>
<VL>79</VL>
<PG>48-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kaul-2002" MODIFIED="2010-08-26 13:59:35 -0700" MODIFIED_BY="[Empty name]" NAME="Kaul 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, MacDonald KS, Maclean IW, Bwayo JJ, Temmerman M, Ronald AR, Moses AR,</AU>
<TI>Monthly Antibiotic Chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>291</VL>
<NO>21</NO>
<PG>2555-2562</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Laga-1993" NAME="Laga 1993" TYPE="JOURNAL_ARTICLE">
<AU>Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al</AU>
<TI>Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study</TI>
<SO>AIDS</SO>
<YR>1993</YR>
<VL>7</VL>
<PG>95-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lin-2008" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Lin 2008" TYPE="JOURNAL_ARTICLE">
<AU>Lin JS, Whitlock E, O'Connor E, Bauer V</AU>
<TI>Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force</TI>
<SO>Ann Intern Med</SO>
<YR>2008</YR>
<VL>149</VL>
<NO>7</NO>
<PG>497-508, W96-99</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Low-2009" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Low 2009" TYPE="JOURNAL_ARTICLE">
<AU>Low N, Bender N, Nartey L, Shang A, Stephenson JM</AU>
<TI>Effectiveness of chlamydia screening: systematic review.</TI>
<SO>Int J Epidemiol</SO>
<YR>2009</YR>
<VL>38</VL>
<NO>2</NO>
<PG>435-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mabey-1996" NAME="Mabey 1996" TYPE="JOURNAL_ARTICLE">
<AU>Mabey DC</AU>
<TI>Sexually transmitted diseases in developing countries</TI>
<SO>Trans R Soc Trop Med Hyg</SO>
<YR>1996</YR>
<VL>90</VL>
<PG>97-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malkin-2004" MODIFIED="2010-08-26 13:59:52 -0700" MODIFIED_BY="[Empty name]" NAME="Malkin 2004" TYPE="JOURNAL_ARTICLE">
<AU>Malkin JE</AU>
<TI>Epidemiology of genital herpes simplex virus infection in developed countries</TI>
<SO>Herpes</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>Suppl 1</NO>
<PG>2A-23A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nagot-2007" MODIFIED="2010-08-20 13:45:52 -0700" MODIFIED_BY="[Empty name]" NAME="Nagot 2007" TYPE="JOURNAL_ARTICLE">
<AU>Nagot N, Ouédraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer MC, Djagbaré D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P</AU>
<TI>Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus</TI>
<SO>N Engl J Med</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>8</NO>
<PG>790-799</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oakeshott-2010" MODIFIED="2011-02-14 14:27:46 -0800" MODIFIED_BY="Tara Horvath" NAME="Oakeshott 2010" TYPE="JOURNAL_ARTICLE">
<AU>Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P</AU>
<TI>Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial</TI>
<SO>BMJ</SO>
<YR>2010 Apr</YR>
<VL>340</VL>
<PG>c1642</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ostergaard-2000" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Ostergaard 2000" TYPE="JOURNAL_ARTICLE">
<AU>Ostergaard L, Andersen B, Muller JK, Olesen F</AU>
<TI>Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.</TI>
<SO>Clin Infect Dis</SO>
<YR>2000</YR>
<VL>31</VL>
<NO>4</NO>
<PG>951-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Robinson-1997" MODIFIED="2011-02-16 10:52:03 -0800" MODIFIED_BY="Tara Horvath" NAME="Robinson 1997" TYPE="JOURNAL_ARTICLE">
<AU>Robinson NJ, Mulder DW, Auvert B, Hayes RJ</AU>
<TI>Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates</TI>
<SO>Intl J Epidemiol</SO>
<YR>1997</YR>
<VL>26</VL>
<PG>180-189</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royce-1997" MODIFIED="2011-02-16 15:45:20 -0800" MODIFIED_BY="Tara Horvath" NAME="Royce 1997" TYPE="JOURNAL_ARTICLE">
<AU>Royce RA, Sena A, Cates W Jr, Cohen MS</AU>
<TI>Sexual transmission of HIV</TI>
<SO>N Engl J Med</SO>
<YR>1997</YR>
<VL>336</VL>
<PG>1072-1078</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scholes-1996" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Scholes 1996" TYPE="JOURNAL_ARTICLE">
<AU>Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE</AU>
<TI>Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.</TI>
<SO>N Engl J Med</SO>
<YR>1996</YR>
<VL>334</VL>
<NO>21</NO>
<PG>1362-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steen-2009" MODIFIED="2010-08-20 15:32:29 -0700" MODIFIED_BY="[Empty name]" NAME="Steen 2009" TYPE="JOURNAL_ARTICLE">
<AU>Steen R, Teodora EW, Kamali A, Ndowa F</AU>
<TI>Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm</TI>
<SO>Bull World Health Organ</SO>
<YR>2007</YR>
<VL>87</VL>
<PG>858-865</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Todd-2003" MODIFIED="2010-08-24 10:08:04 -0700" MODIFIED_BY="[Empty name]" NAME="Todd 2003" TYPE="JOURNAL_ARTICLE">
<AU>Todd J, Carpenter L, Li X, Nakiyingi J, Gray R, Hayes R</AU>
<TI>The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2003</YR>
<VL>32</VL>
<PG>755-762</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-UNAIDS-2008" MODIFIED="2010-08-06 11:39:22 -0700" MODIFIED_BY="[Empty name]" NAME="UNAIDS 2008" TYPE="OTHER">
<AU>UNAIDS</AU>
<TI>Status on the global HIV epidemic</TI>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Walker-2007" MODIFIED="2010-08-19 14:18:22 -0700" MODIFIED_BY="[Empty name]" NAME="Walker 2007" TYPE="JOURNAL_ARTICLE">
<AU>Walker GJA, Walker DG</AU>
<TI>Congenital syphilis: A continuing but neglected problem</TI>
<SO>Seminars in Fetal &amp; Neonatal Medicine</SO>
<YR>2007</YR>
<VL>12</VL>
<PG>198-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wasserheit-1989" MODIFIED="2011-02-16 10:52:12 -0800" MODIFIED_BY="Tara Horvath" NAME="Wasserheit 1989" TYPE="JOURNAL_ARTICLE">
<AU>Wasserheit J</AU>
<TI>The significance and scope of reproductive tract infections among Third World women</TI>
<SO>Intl J Gynaecol Obstet</SO>
<YR>1989</YR>
<VL>Suppl 3</VL>
<PG>145-168</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wasserheit-1992" MODIFIED="2011-02-16 15:43:56 -0800" MODIFIED_BY="Tara Horvath" NAME="Wasserheit 1992" TYPE="JOURNAL_ARTICLE">
<AU>Wasserheit JN</AU>
<TI>Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases</TI>
<SO>Sex Transm Dis</SO>
<YR>1992</YR>
<VL>19</VL>
<PG>61-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Watson_x002d_Jones-2008" MODIFIED="2010-08-20 13:51:06 -0700" MODIFIED_BY="[Empty name]" NAME="Watson-Jones 2008" TYPE="JOURNAL_ARTICLE">
<AU>Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, Tanton C, Ross D, Everett D, Clayton T, Balira R, Knight L, Hambleton I, Le Goff J, Belec L, Hayes R</AU>
<TI>Effect of herpes simplex suppression on incidence of HIV among women in Tanzania</TI>
<SO>N Engl J Med</SO>
<YR>2008</YR>
<VL>358</VL>
<NO>15</NO>
<PG>1560-1571</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1999" MODIFIED="2011-02-16 12:16:11 -0800" MODIFIED_BY="Tara Horvath" NAME="WHO 1999" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Sexually transmitted infections: Fact sheet No 110</TI>
<SO>Available from http://www.who.int/mediacentre/factsheets/fs110/en/</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2001" MODIFIED="2011-02-16 12:16:25 -0800" MODIFIED_BY="Tara Horvath" NAME="WHO 2001" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections</TI>
<SO>Available from http://www.who.int/docstore/hiv/GRSTI/</SO>
<CY>Washington, DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Workowski-2006" MODIFIED="2011-02-16 16:16:44 -0800" MODIFIED_BY="Tara Horvath" NAME="Workowski 2006" TYPE="JOURNAL_ARTICLE">
<AU>Workowski KA, Berman SM</AU>
<TI>Sexually transmitted diseases treatment guidelines, 2006</TI>
<SO>MMWR Recomm Rep</SO>
<YR>2006 Aug 4</YR>
<VL>55</VL>
<NO>RR-11</NO>
<PG>1-94</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-02-14 14:53:35 -0800" MODIFIED_BY="Tara Horvath">
<REFERENCE ID="REF-Sangani-2004" MODIFIED="2010-08-26 14:50:13 -0700" MODIFIED_BY="[Empty name]" NAME="Sangani 2004" TYPE="COCHRANE_REVIEW">
<AU>Sangani P, Rutherford G, Kennedy GE</AU>
<TI>Population-based interventions for reducing sexually transmitted infections, including HIV infection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2010-08-17 16:16:08 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-08-17 16:16:01 -0700" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.cd001220.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wilkinson-1998" MODIFIED="2011-02-14 14:52:55 -0800" MODIFIED_BY="Tara Horvath" NAME="Wilkinson 1998" TYPE="COCHRANE_PROTOCOL">
<AU>Wilkinson D, Rutherford GW</AU>
<TI>Population-based interventions for reducing sexually transmitted infections, including HIV infection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-02-14 14:52:05 -0800" MODIFIED_BY="Tara Horvath">
<IDENTIFIER TYPE="DOI" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wilkinson-2001" MODIFIED="2011-02-14 14:53:35 -0800" MODIFIED_BY="Tara Horvath" NAME="Wilkinson 2001" TYPE="COCHRANE_REVIEW">
<AU>Wilkinson D, Rutherford GW</AU>
<TI>Population-based interventions for reducing sexually transmitted infections, including HIV infection</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2010-08-26 14:00:29 -0700" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="DOI" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-02-16 22:17:12 -0800" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-02-16 22:17:12 -0800" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-02-14 14:56:18 -0800" MODIFIED_BY="Tara Horvath" STUDY_ID="STD-Gregson-2007">
<CHAR_METHODS MODIFIED="2010-08-11 09:23:32 -0700" MODIFIED_BY="[Empty name]">
<P>Community randomised trial in eastern Zimbabwe</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-08-11 09:24:09 -0700" MODIFIED_BY="[Empty name]">
<P>Approximately 11,000 participants in 12 communities</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-02-14 14:56:18 -0800" MODIFIED_BY="Tara Horvath">
<P>The program comprised three key components: (1) peer education and condom distribution amongst commercial sex workers and male clients at workplaces and in the general community, supported by income-generating projects; (2) strengthened syndromic management of STI services at local health centres; and (3) open days with HIV/AIDS IEC activities at health enters to promote safer sex behavior and to increase the uptake of local STI treatment services.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-11 09:25:31 -0700" MODIFIED_BY="[Empty name]">
<P>Incidence of HIV-1, self-reported STI symptoms, high-risk sexual behaviour</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Grosskurth-1995">
<CHAR_METHODS>
<P>Community randomised trial in Mwanza, Tanzania</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Approximately 12,000 adults aged 15-54 in 12 communities</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Improved STD case management</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HIV incidence</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-08-26 13:51:47 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamali-2003">
<CHAR_METHODS>
<P>Community randomised trial in rural Uganda</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Approximately 20,000 adults aged 13 - 65 in 18 communities</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-08-26 13:51:47 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral interventions including knowledge, skills training and support versus behavioral interventions PLUS syndromic STI management versus control group receiving community development and health-related issues chosen by each community</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HIV-1 incidence</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wawer-1999">
<CHAR_METHODS>
<P>Community randomised trial in Rakai, Uganda</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Approximately 14,000 consenting adults aged 15-59 in 10 community clusters</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Mass treatment of all participants with azithromycin, ciprofloxacin, and metronidazole</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HIV and STD infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2011-02-16 15:51:54 -0800" MODIFIED_BY="Tara Horvath" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:51:10 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Asamoah_x002d_Adu-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:51:10 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:24:39 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Basu-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:24:39 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:13:13 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-CDC-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:13:13 -0700" MODIFIED_BY="[Empty name]">
<P>Not a randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:30:27 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clark-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:30:27 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:08:25 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coates-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:08:25 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:29:55 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cowan-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:29:55 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:02:53 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deren-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:02:53 -0700" MODIFIED_BY="[Empty name]">
<P>Not general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:25:58 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Doyle-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:25:58 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:13:46 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feldblum-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:13:46 -0700" MODIFIED_BY="[Empty name]">
<P>No HIV outcomes reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:31:28 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Figueiredo-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:31:28 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:39:13 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Figueroa-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:39:13 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-18 15:59:36 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-18 15:59:36 -0700" MODIFIED_BY="[Empty name]">
<P>No HIV outcomes reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:29:20 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garcia-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:29:20 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:43:31 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Golub-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:43:31 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:19:47 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grosskurth-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:19:47 -0700" MODIFIED_BY="[Empty name]">
<P>No HIV outcomes reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:03:47 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harvey-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:03:47 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:05:05 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayes-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:05:05 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:18:49 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hayes-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:18:49 -0700" MODIFIED_BY="[Empty name]">
<P>Preliminary study only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:29:37 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hudson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:29:37 -0700" MODIFIED_BY="[Empty name]">
<P>Not a study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:28:13 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jana-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:28:13 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:08:44 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamb-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:08:44 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:32:07 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kegeles-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:32:07 -0700" MODIFIED_BY="[Empty name]">
<P>Not general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:02:20 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kelly-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:02:20 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:30:27 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lauby-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:30:27 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:36:41 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maher-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:36:41 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-18 15:59:43 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mayaud-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-18 15:59:43 -0700" MODIFIED_BY="[Empty name]">
<P>No HIV outcomes reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:11:32 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MMWR-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:11:32 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:10:29 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NIMH-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:10:29 -0700" MODIFIED_BY="[Empty name]">
<P>Not community randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:28:43 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NIMH-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:28:43 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:39:11 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pronyk-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:39:11 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:39:03 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pronyk-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:39:03 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:36:31 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pronyk-2008a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:36:31 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:05:38 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quigley-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:05:38 -0700" MODIFIED_BY="[Empty name]">
<P>Not a randomised study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:39:25 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ramesh-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:39:25 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:39:24 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reza_x002d_Paul-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:39:24 -0700" MODIFIED_BY="[Empty name]">
<P>Not the general population.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:38:53 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robinson-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:38:53 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:47:09 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sieverding-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:47:09 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:32:10 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sikkema-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:32:10 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:32:33 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-St.-Lawrence-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:32:33 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 15:37:20 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sun-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 15:37:20 -0700" MODIFIED_BY="[Empty name]">
<P>No HIV outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:27:53 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:27:53 -0700" MODIFIED_BY="[Empty name]">
<P>Not a study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-08-17 14:27:19 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-08-17 14:27:19 -0700" MODIFIED_BY="[Empty name]">
<P>Behavioral intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-02-16 22:17:12 -0800" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-02-14 14:56:29 -0800" MODIFIED_BY="Tara Horvath" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-16 15:39:35 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>Un-blinded coin toss by Ministry of Health official witnessed by programme and research personnel. </P>
<P>Twelve total communities were paired, matched by socioeconomic type. Within each pair, one community was assigned at random to receive the additional intervention, and the other to be the control.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-14 14:56:24 -0800" MODIFIED_BY="Tara Horvath" RESULT="UNKNOWN" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION>
<P>
<B>&#8220;In each matched pair, one community was randomly chosen to receive the STD intervention immediately following the baseline survey...&#8221;</B>
</P>
<P>12 large communities were selected as the elements of randomisation.  Communities were matched into six pairs according to the following criteria, roadside, lakeshore, island, or rural location; geographical area (paired communities were generally in the same district and less than 50 km apart) and prior STD attendance rates at the health centre. In each matched pair, one community was randomly chosen to receive the STD intervention immediately following the baseline survey, whereas the comparison community received the intervention after the follow-up survey 2 years later.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-16 15:33:28 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION>
<P>
<B>"The names of communities were written on separate cards, shuffled, and one picked at random." </B>
</P>
<P>18 rural communities were randomly assigned to group A, B, or C. Six triplets were first formed by matching on type of main road passing through, distance from the district capital and quality of the local government health facility.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-14 14:56:29 -0800" MODIFIED_BY="Tara Horvath" RESULT="UNKNOWN" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION>
<P>
<B>&#8220;Clusters were grouped into three blocks, based on model projections of prevalence of intervention or control...&#8221;</B>
</P>
<P>56 communities were selected from among trading villages on secondary roads in the south and central regions of the district. Communities were aggregated into ten clusters of four to seven contiguous villages. Clusters were grouped into three blocks, based on model projections of prevalence of HIV-1 infection and were randomly assigned within blocks to intervention or control.  Before analysis, the clusters were paired within randomisation blocks; pairing was based on observed prevalence of HIV-1 infection at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2010-08-23 11:14:15 -0700" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-23 11:14:15 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>Usually not an issue with cluster-randomised trials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-23 11:13:33 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION>
<P>Usually not an issue with cluster-randomised trials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-23 11:14:00 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION>
<P>Usually not an issue with cluster-randomised trials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-23 11:13:45 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION>
<P>Usually not an issue with cluster-randomised trials.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-08-23 13:59:28 -0700" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-23 13:59:02 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>Participants: no, not possible.</P>
<P>Personnel: no, not possible.</P>
<P>Outcome assessors: unclear.</P>
<P>Lack of blinding would not have affected study results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-23 13:59:28 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION>
<P>Participants: no, not possible.</P>
<P>Personnel: no, not possible.</P>
<P>Outcome assessors: unclear.</P>
<P>Lack of blinding would not have affected study results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-16 15:35:07 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION>
<P>Participants: no, not possible.</P>
<P>Personnel: no, not possible.</P>
<P>Outcome assessors: yes. (&#8220;...the trial research team remained blind to the data until the end of the study.&#8221;)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2010-08-23 13:59:19 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION>
<P>Participants: yes.</P>
<P>Personnel: no, not possible.</P>
<P>Outcome assessors: unclear.</P>
<P>Lack of blinding would not have affected study results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-08-26 13:51:35 -0700" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2010-08-16 15:41:08 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>
<B>&#8220;At both baseline and follow-up, migrants and non-migrants had similar risks of HIV-1 infection and associated behavior. &#8220;</B> </P>
<P>In Round 1, for the intervention group, 4792 were bled and interviewed (11 interviewed only) and 210 refused and 930 were absent of the initial 5943 who were eligible. After Round 1, of the 4792 who had enrolled in Round 1, 1044 migrated away and were lost to follow-up and 214 had died, making 3534 eligible. Of these, 22 refused, 794 were absent and 23 did not get interviewed due to other reasons so only 2664 were bled and interviewed (31 interviewed only). </P>
<P>For the comparison group, 6037 were eligible in Round 1, and 4662 were bled and interviewed (19 interviewed only). 219 refused and 1137 were absent. After Round 1, 1144 migrated away and were lost to follow-up and 176 had died, leaving 3342 eligible. Of these, 2564 were bled and interviewed for Round 2 (37 interviewed only), whereas for the rest, 17 refused, 698 were absent and 26 did not consent for other reasons. </P>
<P>Overall, the proportions of baseline respondents followed up at the end of the study were 55 and 56% in the intervention, and comparison communities, respectively.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2010-08-26 13:50:22 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION>
<P>
<B>Losses due to &#8220;other&#8221; reasons occurred more frequently in the intervention group (11% vs. 5%) </B>
</P>
<P>
<B>Men</B>: Intervention: 2881 recruited, 2052 (71%) seen at follow-up. Comparison:  2998 recruited, 2187 seen at follow-up (73%). Total: 5879 recruited, 4239 seen at follow-up (72%). </P>
<P>
<B>Women</B>: Intervention: 3261 recruited, 2234 seen at follow-up (69%). Comparison: 3397 recruited, 2372 seen at follow-up (70%). Total: 6658 recruited, 4606 seen at follow-up (69%). </P>
<P>
<B>Total</B>:<B> </B>Intervention: 6142 recruited, 4286 seen at follow-up (70%). Comparison: 6395 recruited, 4559 seen at follow-up (71%). Total: 12537 recruited, 8845 seen at follow-up (71%). </P>
<P>Reasons for losses to follow-up included &#8220;moved&#8221;, &#8220;temporary absence&#8221;, &#8220;died&#8221;, or &#8220;other.&#8221; </P>
<P>No re-inclusions in analyses were performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2010-08-26 13:51:35 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION>
<P>Large numbers refused to participate. Numbers approximately across groups, but characteristics of those who refused not addressed. Problems with external validity. </P>
<P>Intent to treat analysis completed. </P>
<P>From Round 1 to 2, 61% that bled at Round 1 also bled at Round 2. </P>
<P>From Round 2 to 3, 76% that bled at Round 2 also bled at Round 3. </P>
<P>From Round 1 to 3, 23% that bled at Round 1 also bled at Round 3. </P>
<P>
<B>Group A</B>:</P>
<P>Round 1: 6918 eligible, 4931 total bled, 89 interviewed only.</P>
<P>Round 2: 7271 eligible, 5130 total bled, 3 interviewed only.</P>
<P>Round 3: 4846 eligible, 4293 total bled, 1 interviewed only.</P>
<P> </P>
<P>
<B>Group B</B>:</P>
<P>Round 1: 6856 eligible, 4787 total bled, 68 interviewed only.</P>
<P>Round 2: 7302 eligible, 5242 total bled, 6 interviewed only.</P>
<P>Round 3: 4861 eligible, 4464 total bled, 1 interviewed only.</P>
<P> </P>
<P>
<B>Group C</B>:</P>
<P>Round 1: 6742 eligible, 4836 total bled, 76 interviewed only.</P>
<P>Round 2: 7014 eligible, 5242 total bled, 3 interviewed only.</P>
<P>Round 3: 4781 eligible, 4463 total bled, 0 interviewed only.</P>
<P> </P>
<P>Reasons for exclusion were either &#8220;refused&#8221;, &#8220;absent&#8221; or &#8220;other. </P>
<P>No re-inclusions in analyses were performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2010-08-16 15:21:38 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION>
<P>&#8220;Individuals lost to follow-up were younger than those who continued under observation. Individuals aged 15 ? 29 years represented 72.3% and 73.5% of those lost to follow-up in the intervention and control groups. However, individuals lost to follow-up did not differ from those who continued in the study as regards other characteristics, sexual behaviours, or STD symptoms(results not shown).&#8221; </P>
<P>
<B>STD intervention</B>:</P>
<P>Round 1: 6993 eligible, 5990 treated.</P>
<P>Round 2: 7760 eligible, 6275 treated.</P>
<P>Round 3: 8162 eligible, 6648 treated. </P>
<P>
<B>Control</B>:</P>
<P>Round 1: 6839 eligible, 6226 treated.</P>
<P>Round 2: 6851 eligible, 5591 treated.</P>
<P>Round 3: 7502 eligible, 6250 treated. </P>
<P>Reasons for not continuing on: &#8220;refused consent&#8221; or &#8220;refused treatment&#8221;. </P>
<P>
<B>STD cohort</B>:</P>
<P>7871 enrolled (round 1 or 2) in intervention clusters, 1728 lost to follow-up, 6143 followed-up.</P>
<P>7256 enrolled (round 1 or 2) in control clusters, 1713 lost to follow-up, 5543 followed-up. </P>
<P>
<B>HIV-1 incidence cohort</B>: </P>
<P>6602 enrolled (round 1 or 2) in intervention clusters, 1675 lost to follow-up, 4927 followed-up.</P>
<P>6124 enrolled (round 1 or 2) in control clusters, 1675 lost to follow-up, 4449 followed-up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-08-20 10:31:45 -0700" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-16 15:42:57 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>Study protocol available online (www.clinicaltrials.gov) and all of the study's pre-specified primary and secondary outcomes that are of interest in the review have been reported in the pre-specified way.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-20 10:31:40 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-20 10:31:45 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-20 10:31:32 -0700" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-02-16 22:17:12 -0800" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-16 15:43:25 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gregson-2007">
<DESCRIPTION>
<P>Although intervention contamination was minimized in the control groups by the authors, a similar peer-education program was implemented in one control community and HIV-1 prevention activity was considerable in all control communities that also had greater access to information from external sources. Contamination may have limited their ability to detect a meaningful reduction in HIV-1 incidence.</P>
<P>Large numbers lost to follow-up in both groups, although the percentages lost to follow-up were similar in both the intervention and comparison groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-16 15:43:07 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Grosskurth-1995">
<DESCRIPTION>
<P>Lack of comparability between the treatment and comparison communities, suggesting a systematic bias in their sequence generation. There may be other uncontrolled factors.</P>
<P>There may be contamination effects.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-23 11:07:39 -0700" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kamali-2003">
<DESCRIPTION>
<P>During the trial, authors noticed substantial secular changes towards safer sexual behavior in the whole study population, unrelated to their interventions, either in response to the HIV-1 epidemic itself or to HIV-specific health education from governmental and non-governmental sources and in the media.</P>
<P>The authors acknowledge that bias in the form of people reporting what they think is the right answer could have occurred.</P>
<P>Study possibly underpowered.</P>
<P>Recruitment bias may be present as they recruited new individuals in the second round, after randomisation of the communities had been done. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-16 22:17:12 -0800" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wawer-1999">
<DESCRIPTION>
<P>Those who dropped out tended to be younger.</P>
<P>Participants may have discerned their randomised assignment.</P>
<P>Ethically mandated STD services also offered to those in control group.</P>
<P>May have required longer duration of follow-up to detect differences in HIV incidence.</P>
<P>People who subsequently moved to the communities were considered eligible. Hence, recruitment bias may be present.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2010-08-16 16:21:23 -0700" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2010-08-20 10:30:37 -0700" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-02-16 15:34:21 -0800" MODIFIED_BY="Tara Horvath">
<COMPARISON ID="CMP-001" MODIFIED="2011-02-16 15:34:21 -0800" MODIFIED_BY="Tara Horvath" NO="1">
<NAME>Any intervention vs control</NAME>
<DICH_OUTCOME CHI2="6.170746130551728" CI_END="1.3087202044022832" CI_START="0.6665465374780708" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339822914659223" ESTIMABLE="YES" EVENTS_1="151" EVENTS_2="152" I2="51.383512843822515" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.11684680722865588" LOG_CI_START="-0.17616952327283975" LOG_EFFECT_SIZE="-0.029661358022091924" METHOD="MH" MODIFIED="2011-02-16 15:34:21 -0800" MODIFIED_BY="Tara Horvath" NO="1" P_CHI2="0.1035922741279387" P_Q="0.0" P_Z="0.6915111588582968" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.05991587759265938" TOTALS="YES" TOTAL_1="11958" TOTAL_2="12023" WEIGHT="100.0" Z="0.3968051429512504">
<NAME>HIV incidence</NAME>
<GROUP_LABEL_1>Favours treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.063470955202037" CI_START="0.9003821251729283" EFFECT_SIZE="1.3630525902830832" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="38" LOG_CI_END="0.31459836025765175" LOG_CI_START="-0.04557313541276435" LOG_EFFECT_SIZE="0.13451261242244372" MODIFIED="2011-02-16 15:34:21 -0800" MODIFIED_BY="Tara Horvath" ORDER="26" O_E="0.0" SE="0.2115665194344599" STUDY_ID="STD-Gregson-2007" TOTAL_1="2549" TOTAL_2="2539" VAR="0.0447603921456117" WEIGHT="28.30157578389248"/>
<DICH_DATA CI_END="1.0477600601853314" CI_START="0.35054929424712644" EFFECT_SIZE="0.606045831301804" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="35" LOG_CI_END="0.020261839452912416" LOG_CI_START="-0.4552509029063555" LOG_EFFECT_SIZE="-0.21749453172672154" MODIFIED="2011-02-16 15:34:20 -0800" MODIFIED_BY="Tara Horvath" ORDER="21796" O_E="0.0" SE="0.2793185386878707" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="3516" TOTAL_2="3729" VAR="0.07801884605472753" WEIGHT="21.477575061854072"/>
<DICH_DATA CI_END="1.3881114568781996" CI_START="0.4023429109745219" EFFECT_SIZE="0.7473264375876578" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" LOG_CI_END="0.14242433871523588" LOG_CI_START="-0.39540364626139485" LOG_EFFECT_SIZE="-0.12648965377307947" MODIFIED="2011-02-16 15:34:20 -0800" MODIFIED_BY="Tara Horvath" ORDER="25" O_E="0.0" SE="0.3159228206667354" STUDY_ID="STD-Kamali-2003" TOTAL_1="2852" TOTAL_2="3009" VAR="0.09980722861802624" WEIGHT="18.547744600365505"/>
<DICH_DATA CI_END="1.4580833847980188" CI_START="0.7106305345346836" EFFECT_SIZE="1.0179187468237123" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="55" LOG_CI_END="0.1637823611027685" LOG_CI_START="-0.14835613558154015" LOG_EFFECT_SIZE="0.007713112760614179" MODIFIED="2011-02-16 14:10:31 -0800" MODIFIED_BY="Tara Horvath" ORDER="21795" O_E="0.0" SE="0.1833516980628407" STUDY_ID="STD-Wawer-1999" TOTAL_1="3041" TOTAL_2="2746" VAR="0.033617845182527105" WEIGHT="31.67310455388793"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="22.786169192859198" CI_END="0.8951308116713169" CI_START="0.8245606225621884" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8591214229352555" ESTIMABLE="YES" EVENTS_1="2971" EVENTS_2="3274" I2="64.8909830683296" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.048113493582700124" LOG_CI_START="-0.0837774090596312" LOG_EFFECT_SIZE="-0.06594545132116565" METHOD="MH" MODIFIED="2011-02-16 15:12:36 -0800" MODIFIED_BY="Tara Horvath" NO="2" P_CHI2="0.0036499112457284433" P_Q="0.0" P_Z="4.2215204670539763E-13" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="71154" TOTAL_2="70771" WEIGHT="100.00000000000003" Z="7.248262441476955">
<NAME>STI incidence and prevalence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1347638752037292" CI_END="0.9646863670355054" CI_START="0.8031703205448144" DF="1" EFFECT_SIZE="0.8802314801443535" ESTIMABLE="YES" EVENTS_1="797" EVENTS_2="875" I2="11.875939845153644" ID="CMP-001.02.01" LOG_CI_END="-0.015613858889529065" LOG_CI_START="-0.09519234833372273" LOG_EFFECT_SIZE="-0.055403103611625884" MODIFIED="2010-08-17 10:11:11 -0700" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.28676151300214936" P_Z="0.00635110245928304" STUDIES="2" TAU2="0.0" TOTAL_1="10498" TOTAL_2="9823" WEIGHT="26.42455210342724" Z="2.729081400487697">
<NAME>Syphilis</NAME>
<DICH_DATA CI_END="1.0357329317465578" CI_START="0.8152184515387261" EFFECT_SIZE="0.9188844306146959" ESTIMABLE="YES" EVENTS_1="445" EVENTS_2="516" LOG_CI_END="0.015247785118423698" LOG_CI_START="-0.08872599913072278" LOG_EFFECT_SIZE="-0.03673910700614953" MODIFIED="2010-08-17 10:11:11 -0700" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.061074715546481334" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="4260" TOTAL_2="4539" VAR="0.003730120879083609" WEIGHT="14.861857457869572"/>
<DICH_DATA CI_END="0.9576320452098769" CI_START="0.7203318807992296" EFFECT_SIZE="0.8305497530188324" ESTIMABLE="YES" EVENTS_1="352" EVENTS_2="359" LOG_CI_END="-0.018801329576410432" LOG_CI_START="-0.14246736358123654" LOG_EFFECT_SIZE="-0.08063434657882348" ORDER="21797" O_E="0.0" SE="0.07264204053117594" STUDY_ID="STD-Wawer-1999" TOTAL_1="6238" TOTAL_2="5284" VAR="0.005276866052533009" WEIGHT="11.562694645557666"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7685558816000957" CI_START="0.5381326979167336" DF="0" EFFECT_SIZE="0.6431057845061209" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="261" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-0.11432454951981239" LOG_CI_START="-0.2691106186329828" LOG_EFFECT_SIZE="-0.19171758407639758" MODIFIED="2010-08-17 10:26:49 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="1.2025825262714388E-6" STUDIES="1" TAU2="0.0" TOTAL_1="1968" TOTAL_2="1815" WEIGHT="8.077488878331268" Z="4.8552116110402155">
<NAME>Trichomoniasis</NAME>
<DICH_DATA CI_END="0.7685558816000957" CI_START="0.5381326979167336" EFFECT_SIZE="0.6431057845061209" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="261" LOG_CI_END="-0.11432454951981239" LOG_CI_START="-0.2691106186329828" LOG_EFFECT_SIZE="-0.19171758407639758" ORDER="21799" O_E="0.0" SE="0.09092210320047557" STUDY_ID="STD-Wawer-1999" TOTAL_1="1968" TOTAL_2="1815" VAR="0.008266828850397931" WEIGHT="8.077488878331268"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9085574942054678" CI_START="0.8276876126030546" DF="0" EFFECT_SIZE="0.8671803637603525" ESTIMABLE="YES" EVENTS_1="1707" EVENTS_2="1827" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="-0.04164758500303808" LOG_CI_START="-0.08213354452133569" LOG_EFFECT_SIZE="-0.06189056476218689" NO="3" P_CHI2="1.0" P_Z="2.068139595776778E-9" STUDIES="1" TAU2="0.0" TOTAL_1="3660" TOTAL_2="3397" WEIGHT="56.369816866718175" Z="5.992362752914727">
<NAME>Bacterial Vaginosis</NAME>
<DICH_DATA CI_END="0.9085574942054678" CI_START="0.8276876126030546" EFFECT_SIZE="0.8671803637603525" ESTIMABLE="YES" EVENTS_1="1707" EVENTS_2="1827" LOG_CI_END="-0.04164758500303808" LOG_CI_START="-0.08213354452133569" LOG_EFFECT_SIZE="-0.06189056476218689" ORDER="21800" O_E="0.0" SE="0.023781653029779797" STUDY_ID="STD-Wawer-1999" TOTAL_1="3660" TOTAL_2="3397" VAR="5.655670208288346E-4" WEIGHT="56.369816866718175"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6017163448251401" CI_END="0.7722857338378968" CI_START="0.3063029389960045" DF="1" EFFECT_SIZE="0.4863675462232589" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="56" I2="0.0" ID="CMP-001.02.04" LOG_CI_END="-0.11222198765639038" LOG_CI_START="-0.51384883609051" LOG_EFFECT_SIZE="-0.31303541187345024" NO="4" P_CHI2="0.4379240786867675" P_Z="0.002248620922572647" STUDIES="2" TAU2="0.0" TOTAL_1="4536" TOTAL_2="4725" WEIGHT="1.6297996849736798" Z="3.055264534976752">
<NAME>Gonorrhoea</NAME>
<DICH_DATA CI_END="0.7532568349663702" CI_START="0.2506361674049119" EFFECT_SIZE="0.4345036319612591" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="42" LOG_CI_END="-0.12305691889826789" LOG_CI_START="-0.6009562590760169" LOG_EFFECT_SIZE="-0.3620065889871424" ORDER="21802" O_E="0.0" SE="0.28072043806029623" STUDY_ID="STD-Kamali-2003" TOTAL_1="3540" TOTAL_2="3589" VAR="0.07880396434476462" WEIGHT="1.240712181711976"/>
<DICH_DATA CI_END="1.547112460930363" CI_START="0.27456173113778953" EFFECT_SIZE="0.6517498565691336" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.18952188408481704" LOG_CI_START="-0.5613599955548034" LOG_EFFECT_SIZE="-0.18591905573499312" ORDER="21801" O_E="0.0" SE="0.441071733025563" STUDY_ID="STD-Wawer-1999" TOTAL_1="996" TOTAL_2="1136" VAR="0.19454427367417354" WEIGHT="0.3890875032617039"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.13322155775035355" CI_END="1.3638321811747656" CI_START="0.7716008685266927" DF="1" EFFECT_SIZE="1.025833366351038" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="94" I2="0.0" ID="CMP-001.02.05" LOG_CI_END="0.1347609339028141" LOG_CI_START="-0.11260729217882992" LOG_EFFECT_SIZE="0.011076820861992069" NO="5" P_CHI2="0.7151150180979668" P_Z="0.8606638507242277" STUDIES="2" TAU2="0.0" TOTAL_1="4537" TOTAL_2="4725" WEIGHT="2.7265477444274895" Z="0.1755291720088652">
<NAME>Chlamydia</NAME>
<DICH_DATA CI_END="1.4853787587132659" CI_START="0.7573459296361884" EFFECT_SIZE="1.0606345067362017" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="0.1718372091045709" LOG_CI_START="-0.12070570436290531" LOG_EFFECT_SIZE="0.02556575237083281" ORDER="21804" O_E="0.0" SE="0.17184115548157206" STUDY_ID="STD-Kamali-2003" TOTAL_1="3540" TOTAL_2="3589" VAR="0.02952938271724182" WEIGHT="1.9201498050304386"/>
<DICH_DATA CI_END="1.608660044243458" CI_START="0.5527497550187193" EFFECT_SIZE="0.94296683152907" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="29" LOG_CI_END="0.20646427498254324" LOG_CI_START="-0.2574714412305546" LOG_EFFECT_SIZE="-0.025503583124005694" ORDER="21803" O_E="0.0" SE="0.2725181362224067" STUDY_ID="STD-Wawer-1999" TOTAL_1="997" TOTAL_2="1136" VAR="0.07426613457013424" WEIGHT="0.8063979393970508"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2967475697758757" CI_START="0.8417042278400592" DF="0" EFFECT_SIZE="1.044738202575974" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="161" I2="0.0" ID="CMP-001.02.06" LOG_CI_END="0.11285544275861203" LOG_CI_START="-0.07484049137822212" LOG_EFFECT_SIZE="0.019007475690194977" MODIFIED="2010-08-24 09:53:56 -0700" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Z="0.6913963395929046" STUDIES="1" TAU2="0.0" TOTAL_1="45955" TOTAL_2="46286" WEIGHT="4.771794722122162" Z="0.3969608394675599">
<NAME>Herpes simplex virus type 2</NAME>
<DICH_DATA CI_END="1.296747569775876" CI_START="0.8417042278400592" EFFECT_SIZE="1.044738202575974" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="161" LOG_CI_END="0.1128554427586121" LOG_CI_START="-0.07484049137822212" LOG_EFFECT_SIZE="0.019007475690194977" MODIFIED="2010-08-24 09:53:56 -0700" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.11025352082183489" STUDY_ID="STD-Kamali-2003" TOTAL_1="45955" TOTAL_2="46286" VAR="0.012155838853610778" WEIGHT="4.771794722122162"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="12.565320865701867" CI_END="1.1628992530437805" CI_START="1.0595690372040538" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1100324508377724" ESTIMABLE="YES" EVENTS_1="4922" EVENTS_2="4055" I2="36.332704230126794" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.0655420915621614" LOG_CI_START="0.025129258828764618" LOG_EFFECT_SIZE="0.04533567519546295" METHOD="MH" MODIFIED="2011-02-16 15:13:04 -0800" MODIFIED_BY="Tara Horvath" NO="3" P_CHI2="0.12770661970248165" P_Q="0.0" P_Z="1.0954046861631853E-5" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0016327425588938706" TOTALS="YES" TOTAL_1="29735" TOTAL_2="27151" WEIGHT="100.00000000000003" Z="4.397429459305545">
<NAME>Safer sexual behaviour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.20990374737304235" CI_END="1.148255885993548" CI_START="0.9810152428905401" DF="1" EFFECT_SIZE="1.061346563050191" ESTIMABLE="YES" EVENTS_1="1102" EVENTS_2="961" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.060038680301993934" LOG_CI_START="-0.008324244554995483" LOG_EFFECT_SIZE="0.02585721787349927" NO="1" P_CHI2="0.6468428693888947" P_Z="0.13816687710866304" STUDIES="2" TAU2="0.0" TOTAL_1="6607" TOTAL_2="6046" WEIGHT="20.570487854858044" Z="1.4826520626050246">
<NAME>Reduced frequency of partner change</NAME>
<DICH_DATA CI_END="1.354756653778691" CI_START="0.9064197339539779" EFFECT_SIZE="1.1081417624521073" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="135" LOG_CI_END="0.131861292692196" LOG_CI_START="-0.04267064787764221" LOG_EFFECT_SIZE="0.04459532240727692" ORDER="21814" O_E="0.0" SE="0.10252092583776234" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="464" TOTAL_2="503" VAR="0.010510540234631967" WEIGHT="4.640637890498546"/>
<DICH_DATA CI_END="1.1471262993540792" CI_START="0.9667439504109909" EFFECT_SIZE="1.0530799638479043" ESTIMABLE="YES" EVENTS_1="964" EVENTS_2="826" LOG_CI_END="0.05961123663959554" LOG_CI_START="-0.01468853692890245" LOG_EFFECT_SIZE="0.02246134985534652" ORDER="21813" O_E="0.0" SE="0.04364405478394651" STUDY_ID="STD-Wawer-1999" TOTAL_1="6143" TOTAL_2="5543" VAR="0.0019048035179841248" WEIGHT="15.929849964359498"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.146320206037341" CI_END="1.331415067604806" CI_START="1.0387782747810088" DF="2" EFFECT_SIZE="1.1760293563274518" ESTIMABLE="YES" EVENTS_1="1514" EVENTS_2="1126" I2="80.28842024116344" ID="CMP-001.03.02" LOG_CI_END="0.1243134675477495" LOG_CI_START="0.01652285812958935" LOG_EFFECT_SIZE="0.0704181628386694" MODIFIED="2010-08-19 09:47:16 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.006262621768194143" P_Z="0.010442048803263382" STUDIES="3" TAU2="0.009461925776422585" TOTAL_1="6983" TOTAL_2="6294" WEIGHT="43.86100417339606" Z="2.560836491532374">
<NAME>Regular condom use with casual partners</NAME>
<DICH_DATA CI_END="1.1757346727904057" CI_START="1.0392630722251848" EFFECT_SIZE="1.1053947838513756" ESTIMABLE="YES" EVENTS_1="510" EVENTS_2="405" LOG_CI_END="0.0703093258693714" LOG_CI_START="0.016725495925001364" LOG_EFFECT_SIZE="0.04351741089718637" MODIFIED="2010-08-19 09:47:16 -0700" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.031475406953559014" STUDY_ID="STD-Gregson-2007" TOTAL_1="622" TOTAL_2="546" VAR="9.90701242892151E-4" WEIGHT="21.480383230740674"/>
<DICH_DATA CI_END="1.3119691680840235" CI_START="1.0011527930043018" EFFECT_SIZE="1.146072247706422" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="128" LOG_CI_END="0.11792362902720918" LOG_CI_START="5.003632882762563E-4" LOG_EFFECT_SIZE="0.059211996157742704" ORDER="21816" O_E="0.0" SE="0.06897500754958895" STUDY_ID="STD-Kamali-2003" TOTAL_1="218" TOTAL_2="205" VAR="0.004757551666465853" WEIGHT="8.818463792017779"/>
<DICH_DATA CI_END="1.4238222307133788" CI_START="1.1693789581530338" EFFECT_SIZE="1.290344045883399" ESTIMABLE="YES" EVENTS_1="848" EVENTS_2="593" LOG_CI_END="0.15345576946962822" LOG_CI_START="0.06795527486107016" LOG_EFFECT_SIZE="0.11070552216534918" ORDER="21815" O_E="0.0" SE="0.05022341376734115" STUDY_ID="STD-Wawer-1999" TOTAL_1="6143" TOTAL_2="5543" VAR="0.0025223912904455523" WEIGHT="13.562157150637608"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.38344687650611714" CI_END="1.1329251520964516" CI_START="1.013843588814585" DF="3" EFFECT_SIZE="1.0717317304529972" ESTIMABLE="YES" EVENTS_1="2306" EVENTS_2="1968" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="0.054201218684895754" LOG_CI_START="0.00597095918438257" LOG_EFFECT_SIZE="0.030086088934639134" MODIFIED="2010-08-17 11:15:35 -0700" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9436403606662425" P_Z="0.014474960537952695" STUDIES="4" TAU2="0.0" TOTAL_1="16145" TOTAL_2="14811" WEIGHT="35.568507971745916" Z="2.4452553794339145">
<NAME>Two or more sexual partners within the past year</NAME>
<DICH_DATA CI_END="1.261571348848748" CI_START="0.790647090620141" EFFECT_SIZE="0.9987280493592786" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="129" LOG_CI_END="0.10091181730706811" LOG_CI_START="-0.10201732281946851" LOG_EFFECT_SIZE="-5.527527562002171E-4" MODIFIED="2010-08-17 11:13:35 -0700" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.11920158142577188" STUDY_ID="STD-Gregson-2007" TOTAL_1="2450" TOTAL_2="2304" VAR="0.014209017014404924" WEIGHT="3.557217112526881"/>
<DICH_DATA CI_END="1.4962093396158673" CI_START="0.7814475457467053" EFFECT_SIZE="1.0812997347480107" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="65" LOG_CI_END="0.1749923613624036" LOG_CI_START="-0.1071001684538906" LOG_EFFECT_SIZE="0.03394609645425652" MODIFIED="2010-08-17 11:08:24 -0700" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.16570254839463439" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="464" TOTAL_2="526" VAR="0.02745733454447615" WEIGHT="1.9371752796126724"/>
<DICH_DATA CI_END="1.2164935613712338" CI_START="0.9401810791326034" EFFECT_SIZE="1.0694504333010812" ESTIMABLE="YES" EVENTS_1="409" EVENTS_2="352" LOG_CI_END="0.08510981464920951" LOG_CI_START="-0.026788493108399355" LOG_EFFECT_SIZE="0.029160660770405068" MODIFIED="2010-08-17 11:06:44 -0700" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="0.06572961988237612" STUDY_ID="STD-Kamali-2003" TOTAL_1="2161" TOTAL_2="1989" VAR="0.0043203829298816545" WEIGHT="9.466049112004518"/>
<DICH_DATA CI_END="1.1502612427888106" CI_START="1.009925414405163" EFFECT_SIZE="1.0778117007611707" ESTIMABLE="YES" EVENTS_1="1698" EVENTS_2="1422" LOG_CI_END="0.06079648680297558" LOG_CI_START="0.004289301200109692" LOG_EFFECT_SIZE="0.032542894001542644" MODIFIED="2010-08-17 11:15:35 -0700" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.03319260053820333" STUDY_ID="STD-Wawer-1999" TOTAL_1="11070" TOTAL_2="9992" VAR="0.001101748730488736" WEIGHT="20.60806646760184"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2011-02-16 13:54:56 -0800" MODIFIED_BY="Tara Horvath" NO="2">
<NAME>STI mass treatment vs. placebo</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4580833847980188" CI_START="0.7106305345346835" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0179187468237123" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="55" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.1637823611027685" LOG_CI_START="-0.14835613558154023" LOG_EFFECT_SIZE="0.007713112760614179" METHOD="MH" MODIFIED="2011-02-16 13:54:56 -0800" MODIFIED_BY="Tara Horvath" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.922834746486809" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3041" TOTAL_2="2746" WEIGHT="100.0" Z="0.09686356140037156">
<NAME>HIV incidence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4580833847980188" CI_START="0.7106305345346836" EFFECT_SIZE="1.0179187468237123" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="55" LOG_CI_END="0.1637823611027685" LOG_CI_START="-0.14835613558154015" LOG_EFFECT_SIZE="0.007713112760614179" MODIFIED="2010-08-24 10:46:04 -0700" MODIFIED_BY="[Empty name]" ORDER="21817" O_E="0.0" SE="0.1833516980628407" STUDY_ID="STD-Wawer-1999" TOTAL_1="3041" TOTAL_2="2746" VAR="0.033617845182527105" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.077918381285626" CI_END="0.8759454571754217" CI_START="0.8016157545588352" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8379568476992473" ESTIMABLE="YES" EVENTS_1="2273" EVENTS_2="2490" I2="63.892133320305355" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.05752293536754745" LOG_CI_START="-0.09603375598440099" LOG_EFFECT_SIZE="-0.07677834567597422" METHOD="MH" MODIFIED="2010-08-23 09:45:41 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.025702160597024126" P_Q="0.0" P_Z="5.492314266622597E-15" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="13859" TOTAL_2="12768" WEIGHT="99.99999999999999" Z="7.815091442202103">
<NAME>STD prevalence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9576320452098769" CI_START="0.7203318807992296" DF="0" EFFECT_SIZE="0.8305497530188324" ESTIMABLE="YES" EVENTS_1="352" EVENTS_2="359" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="-0.018801329576410432" LOG_CI_START="-0.14246736358123654" LOG_EFFECT_SIZE="-0.08063434657882348" NO="1" P_CHI2="1.0" P_Z="0.010590662584097417" STUDIES="1" TAU2="0.0" TOTAL_1="6238" TOTAL_2="5284" WEIGHT="14.976519506047325" Z="2.555922755722027">
<NAME>Syphilis</NAME>
<DICH_DATA CI_END="0.9576320452098769" CI_START="0.7203318807992296" EFFECT_SIZE="0.8305497530188324" ESTIMABLE="YES" EVENTS_1="352" EVENTS_2="359" LOG_CI_END="-0.018801329576410432" LOG_CI_START="-0.14246736358123654" LOG_EFFECT_SIZE="-0.08063434657882348" ORDER="21818" O_E="0.0" SE="0.07264204053117594" STUDY_ID="STD-Wawer-1999" TOTAL_1="6238" TOTAL_2="5284" VAR="0.005276866052533009" WEIGHT="14.976519506047325"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7685558816000957" CI_START="0.5381326979167336" DF="0" EFFECT_SIZE="0.6431057845061209" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="261" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="-0.11432454951981239" LOG_CI_START="-0.2691106186329828" LOG_EFFECT_SIZE="-0.19171758407639758" NO="2" P_CHI2="1.0" P_Z="1.2025825262714388E-6" STUDIES="1" TAU2="0.0" TOTAL_1="1968" TOTAL_2="1815" WEIGHT="10.4623250422587" Z="4.8552116110402155">
<NAME>Trichomoniasis</NAME>
<DICH_DATA CI_END="0.7685558816000957" CI_START="0.5381326979167336" EFFECT_SIZE="0.6431057845061209" ESTIMABLE="YES" EVENTS_1="182" EVENTS_2="261" LOG_CI_END="-0.11432454951981239" LOG_CI_START="-0.2691106186329828" LOG_EFFECT_SIZE="-0.19171758407639758" ORDER="21819" O_E="0.0" SE="0.09092210320047557" STUDY_ID="STD-Wawer-1999" TOTAL_1="1968" TOTAL_2="1815" VAR="0.008266828850397931" WEIGHT="10.4623250422587"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9085574942054678" CI_START="0.8276876126030546" DF="0" EFFECT_SIZE="0.8671803637603525" ESTIMABLE="YES" EVENTS_1="1707" EVENTS_2="1827" I2="0.0" ID="CMP-002.02.03" LOG_CI_END="-0.04164758500303808" LOG_CI_START="-0.08213354452133569" LOG_EFFECT_SIZE="-0.06189056476218689" NO="3" P_CHI2="1.0" P_Z="2.068139595776778E-9" STUDIES="1" TAU2="0.0" TOTAL_1="3660" TOTAL_2="3397" WEIGHT="73.01270921143515" Z="5.992362752914727">
<NAME>Bacterial Vaginosis</NAME>
<DICH_DATA CI_END="0.9085574942054678" CI_START="0.8276876126030546" EFFECT_SIZE="0.8671803637603525" ESTIMABLE="YES" EVENTS_1="1707" EVENTS_2="1827" LOG_CI_END="-0.04164758500303808" LOG_CI_START="-0.08213354452133569" LOG_EFFECT_SIZE="-0.06189056476218689" ORDER="21820" O_E="0.0" SE="0.023781653029779797" STUDY_ID="STD-Wawer-1999" TOTAL_1="3660" TOTAL_2="3397" VAR="5.655670208288346E-4" WEIGHT="73.01270921143515"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.534323197756424E-31" CI_END="1.5471124609303635" CI_START="0.27456173113778953" DF="0" EFFECT_SIZE="0.6517498565691338" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" I2="100.0" ID="CMP-002.02.04" LOG_CI_END="0.18952188408481718" LOG_CI_START="-0.5613599955548034" LOG_EFFECT_SIZE="-0.18591905573499304" NO="4" P_CHI2="0.0" P_Z="0.3317585619477117" STUDIES="1" TAU2="0.0" TOTAL_1="996" TOTAL_2="1136" WEIGHT="0.5039635448988471" Z="0.9705778316428932">
<NAME>Gonorrhoea</NAME>
<DICH_DATA CI_END="1.547112460930363" CI_START="0.27456173113778953" EFFECT_SIZE="0.6517498565691336" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.18952188408481704" LOG_CI_START="-0.5613599955548034" LOG_EFFECT_SIZE="-0.18591905573499312" ORDER="21821" O_E="0.0" SE="0.441071733025563" STUDY_ID="STD-Wawer-1999" TOTAL_1="996" TOTAL_2="1136" VAR="0.19454427367417354" WEIGHT="0.5039635448988471"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.608660044243458" CI_START="0.5527497550187193" DF="0" EFFECT_SIZE="0.94296683152907" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="29" I2="0.0" ID="CMP-002.02.05" LOG_CI_END="0.20646427498254324" LOG_CI_START="-0.2574714412305546" LOG_EFFECT_SIZE="-0.025503583124005694" NO="5" P_CHI2="1.0" P_Z="0.8293874901740101" STUDIES="1" TAU2="0.0" TOTAL_1="997" TOTAL_2="1136" WEIGHT="1.0444826953599644" Z="0.2154872007173285">
<NAME>Chlamydia</NAME>
<DICH_DATA CI_END="1.608660044243458" CI_START="0.5527497550187193" EFFECT_SIZE="0.94296683152907" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="29" LOG_CI_END="0.20646427498254324" LOG_CI_START="-0.2574714412305546" LOG_EFFECT_SIZE="-0.025503583124005694" ORDER="21822" O_E="0.0" SE="0.2725181362224067" STUDY_ID="STD-Wawer-1999" TOTAL_1="997" TOTAL_2="1136" VAR="0.07426613457013424" WEIGHT="1.0444826953599644"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3185177994060104" CI_START="1.1288044918125366" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2199790221574656" ESTIMABLE="YES" EVENTS_1="1229" EVENTS_2="909" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.12008599695208053" LOG_CI_START="0.05261872892268854" LOG_EFFECT_SIZE="0.08635236293738456" METHOD="MH" MODIFIED="2010-08-25 11:06:49 -0700" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="5.243699398223496E-7" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="6143" TOTAL_2="5543" WEIGHT="100.0" Z="5.017174291494145">
<NAME>Treatment seeking behaviour / service use</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3185177994060104" CI_START="1.1288044918125366" DF="0" EFFECT_SIZE="1.2199790221574656" ESTIMABLE="YES" EVENTS_1="1229" EVENTS_2="909" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.12008599695208053" LOG_CI_START="0.05261872892268854" LOG_EFFECT_SIZE="0.08635236293738456" NO="1" P_CHI2="1.0" P_Z="5.243699398223496E-7" STUDIES="1" TAU2="0.0" TOTAL_1="6143" TOTAL_2="5543" WEIGHT="100.0" Z="5.017174291494145">
<NAME>Number seeking care</NAME>
<DICH_DATA CI_END="1.3185177994060104" CI_START="1.1288044918125366" EFFECT_SIZE="1.2199790221574656" ESTIMABLE="YES" EVENTS_1="1229" EVENTS_2="909" LOG_CI_END="0.12008599695208053" LOG_CI_START="0.05261872892268854" LOG_EFFECT_SIZE="0.08635236293738456" ORDER="21823" O_E="0.0" SE="0.03963060720882777" STUDY_ID="STD-Wawer-1999" TOTAL_1="6143" TOTAL_2="5543" VAR="0.0015705850277403918" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="9.331595370446582" CI_END="1.2290084525940936" CI_START="1.0802529289809522" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1522326070100244" ESTIMABLE="YES" EVENTS_1="1812" EVENTS_2="1419" I2="89.28371880367823" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.08955486978828413" LOG_CI_START="0.03352545252415237" LOG_EFFECT_SIZE="0.061540161156218236" METHOD="MH" MODIFIED="2010-08-25 11:06:49 -0700" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0022523737165504043" P_Q="0.0" P_Z="1.6663125281654398E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="12286" TOTAL_2="11086" WEIGHT="100.0" Z="4.3054704245940245">
<NAME>Safer sexual behaviour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1471262993540792" CI_START="0.9667439504109909" DF="0" EFFECT_SIZE="1.0530799638479043" ESTIMABLE="YES" EVENTS_1="964" EVENTS_2="826" I2="0.0" ID="CMP-002.04.01" LOG_CI_END="0.05961123663959554" LOG_CI_START="-0.01468853692890245" LOG_EFFECT_SIZE="0.02246134985534652" NO="1" P_CHI2="1.0" P_Z="0.23600873117706422" STUDIES="1" TAU2="0.0" TOTAL_1="6143" TOTAL_2="5543" WEIGHT="58.210007047216344" Z="1.1850220975450843">
<NAME>Reduced frequency of partner change</NAME>
<DICH_DATA CI_END="1.1471262993540792" CI_START="0.9667439504109909" EFFECT_SIZE="1.0530799638479043" ESTIMABLE="YES" EVENTS_1="964" EVENTS_2="826" LOG_CI_END="0.05961123663959554" LOG_CI_START="-0.01468853692890245" LOG_EFFECT_SIZE="0.02246134985534652" ORDER="21824" O_E="0.0" SE="0.04364405478394651" STUDY_ID="STD-Wawer-1999" TOTAL_1="6143" TOTAL_2="5543" VAR="0.0019048035179841248" WEIGHT="58.210007047216344"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4238222307133788" CI_START="1.1693789581530338" DF="0" EFFECT_SIZE="1.290344045883399" ESTIMABLE="YES" EVENTS_1="848" EVENTS_2="593" I2="0.0" ID="CMP-002.04.02" LOG_CI_END="0.15345576946962822" LOG_CI_START="0.06795527486107016" LOG_EFFECT_SIZE="0.11070552216534918" NO="2" P_CHI2="1.0" P_Z="3.864804421097264E-7" STUDIES="1" TAU2="0.0" TOTAL_1="6143" TOTAL_2="5543" WEIGHT="41.789992952783656" Z="5.07549897406247">
<NAME>Regular condom use with casual partners</NAME>
<DICH_DATA CI_END="1.4238222307133788" CI_START="1.1693789581530338" EFFECT_SIZE="1.290344045883399" ESTIMABLE="YES" EVENTS_1="848" EVENTS_2="593" LOG_CI_END="0.15345576946962822" LOG_CI_START="0.06795527486107016" LOG_EFFECT_SIZE="0.11070552216534918" ORDER="21825" O_E="0.0" SE="0.05022341376734115" STUDY_ID="STD-Wawer-1999" TOTAL_1="6143" TOTAL_2="5543" VAR="0.0025223912904455523" WEIGHT="41.789992952783656"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2011-02-16 15:14:44 -0800" MODIFIED_BY="Tara Horvath" NO="3">
<NAME>Improved STI syndromic management vs. usual care</NAME>
<DICH_OUTCOME CHI2="6.079719559971732" CI_END="1.4856109937357747" CI_START="0.5188176269885938" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8779300486930387" ESTIMABLE="YES" EVENTS_1="89" EVENTS_2="97" I2="67.10374581801764" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.1719051045854641" LOG_CI_START="-0.28498527704857485" LOG_EFFECT_SIZE="-0.05654008623155537" METHOD="MH" MODIFIED="2011-02-16 15:14:44 -0800" MODIFIED_BY="Tara Horvath" NO="1" P_CHI2="0.04784174505039551" P_Q="0.0" P_Z="0.6276123359304797" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.14430557331048915" TOTALS="YES" TOTAL_1="8917" TOTAL_2="9277" WEIGHT="100.0" Z="0.485090241122211">
<NAME>HIV incidence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.063470955202037" CI_START="0.9003821251729283" EFFECT_SIZE="1.3630525902830832" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="38" LOG_CI_END="0.31459836025765175" LOG_CI_START="-0.04557313541276435" LOG_EFFECT_SIZE="0.13451261242244372" MODIFIED="2010-08-24 10:52:47 -0700" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.2115665194344599" STUDY_ID="STD-Gregson-2007" TOTAL_1="2549" TOTAL_2="2539" VAR="0.0447603921456117" WEIGHT="38.09657019450513"/>
<DICH_DATA CI_END="1.0477600601853314" CI_START="0.35054929424712644" EFFECT_SIZE="0.606045831301804" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="35" LOG_CI_END="0.020261839452912416" LOG_CI_START="-0.4552509029063555" LOG_EFFECT_SIZE="-0.21749453172672154" MODIFIED="2010-08-24 10:52:16 -0700" MODIFIED_BY="[Empty name]" ORDER="21826" O_E="0.0" SE="0.2793185386878707" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="3516" TOTAL_2="3729" VAR="0.07801884605472753" WEIGHT="32.397542496481705"/>
<DICH_DATA CI_END="1.3881114568781996" CI_START="0.4023429109745219" EFFECT_SIZE="0.7473264375876578" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="24" LOG_CI_END="0.14242433871523588" LOG_CI_START="-0.39540364626139485" LOG_EFFECT_SIZE="-0.12648965377307947" MODIFIED="2010-08-24 10:52:34 -0700" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="0.3159228206667354" STUDY_ID="STD-Kamali-2003" TOTAL_1="2852" TOTAL_2="3009" VAR="0.09980722861802624" WEIGHT="29.50588730901317"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.5984185504177177" CI_END="1.0526118538793614" CI_START="0.8658107038934131" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9546531360310091" ESTIMABLE="YES" EVENTS_1="714" EVENTS_2="784" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.022268256471120428" LOG_CI_START="-0.06257704936935232" LOG_EFFECT_SIZE="-0.02015439644911595" METHOD="MH" MODIFIED="2011-02-16 10:47:30 -0800" MODIFIED_BY="Tara Horvath" NO="2" P_CHI2="0.6597485070040529" P_Q="0.0" P_Z="0.35177552656113764" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="57094" TOTAL_2="58003" WEIGHT="100.0" Z="0.9311508934785663">
<NAME>STD prevalence</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0357329317465578" CI_START="0.8152184515387261" DF="0" EFFECT_SIZE="0.9188844306146959" ESTIMABLE="YES" EVENTS_1="445" EVENTS_2="516" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.015247785118423698" LOG_CI_START="-0.08872599913072278" LOG_EFFECT_SIZE="-0.03673910700614953" MODIFIED="2010-08-17 11:43:53 -0700" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.16602023188885168" STUDIES="1" TAU2="0.0" TOTAL_1="4260" TOTAL_2="4539" WEIGHT="65.30382601574381" Z="1.3851054297238843">
<NAME>Syphilis</NAME>
<DICH_DATA CI_END="1.0357329317465578" CI_START="0.8152184515387261" EFFECT_SIZE="0.9188844306146959" ESTIMABLE="YES" EVENTS_1="445" EVENTS_2="516" LOG_CI_END="0.015247785118423698" LOG_CI_START="-0.08872599913072278" LOG_EFFECT_SIZE="-0.03673910700614953" MODIFIED="2010-08-17 11:43:53 -0700" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.061074715546481334" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="4260" TOTAL_2="4539" VAR="0.003730120879083609" WEIGHT="65.30382601574381"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2967475697758757" CI_START="0.8417042278400592" DF="0" EFFECT_SIZE="1.044738202575974" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="161" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="0.11285544275861203" LOG_CI_START="-0.07484049137822212" LOG_EFFECT_SIZE="0.019007475690194977" MODIFIED="2010-08-24 09:55:50 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6913963395929046" STUDIES="1" TAU2="0.0" TOTAL_1="45955" TOTAL_2="46286" WEIGHT="20.967530687175632" Z="0.3969608394675599">
<NAME>Herpes simplex virus type 2</NAME>
<DICH_DATA CI_END="1.296747569775876" CI_START="0.8417042278400592" EFFECT_SIZE="1.044738202575974" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="161" LOG_CI_END="0.1128554427586121" LOG_CI_START="-0.07484049137822212" LOG_EFFECT_SIZE="0.019007475690194977" MODIFIED="2010-08-24 09:55:50 -0700" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.11025352082183489" STUDY_ID="STD-Kamali-2003" TOTAL_1="45955" TOTAL_2="46286" VAR="0.012155838853610778" WEIGHT="20.967530687175632"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.6584612953045753E-31" CI_END="1.3642287315742692" CI_START="0.5549912550319237" DF="0" EFFECT_SIZE="0.8701350561188838" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="42" I2="100.0" ID="CMP-003.02.03" LOG_CI_END="0.13488719182521536" LOG_CI_START="-0.2557138599787677" LOG_EFFECT_SIZE="-0.06041333407677617" MODIFIED="2011-02-16 10:47:30 -0800" MODIFIED_BY="Tara Horvath" NO="3" P_CHI2="0.0" P_Z="0.544324910095382" STUDIES="1" TAU2="0.0" TOTAL_1="3339" TOTAL_2="3589" WEIGHT="5.2913985484119" Z="0.6062859197618792">
<NAME>Gonorrhoea</NAME>
<DICH_DATA CI_END="1.364228731574269" CI_START="0.5549912550319236" EFFECT_SIZE="0.8701350561188836" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="42" LOG_CI_END="0.13488719182521527" LOG_CI_START="-0.2557138599787678" LOG_EFFECT_SIZE="-0.06041333407677622" MODIFIED="2010-08-18 09:09:40 -0700" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.22944099133604925" STUDY_ID="STD-Kamali-2003" TOTAL_1="3339" TOTAL_2="3589" VAR="0.05264316850526903" WEIGHT="5.2913985484119"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.4853787587132659" CI_START="0.7573459296361884" DF="0" EFFECT_SIZE="1.0606345067362017" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" I2="0.0" ID="CMP-003.02.04" LOG_CI_END="0.1718372091045709" LOG_CI_START="-0.12070570436290531" LOG_EFFECT_SIZE="0.02556575237083281" MODIFIED="2011-02-16 10:47:30 -0800" MODIFIED_BY="Tara Horvath" NO="4" P_CHI2="1.0" P_Z="0.7319233075253196" STUDIES="1" TAU2="0.0" TOTAL_1="3540" TOTAL_2="3589" WEIGHT="8.437244748668657" Z="0.34256822898615596">
<NAME>Chlamydia</NAME>
<DICH_DATA CI_END="1.4853787587132659" CI_START="0.7573459296361884" EFFECT_SIZE="1.0606345067362017" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="65" LOG_CI_END="0.1718372091045709" LOG_CI_START="-0.12070570436290531" LOG_EFFECT_SIZE="0.02556575237083281" MODIFIED="2010-08-17 11:44:34 -0700" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.17184115548157206" STUDY_ID="STD-Kamali-2003" TOTAL_1="3540" TOTAL_2="3589" VAR="0.02952938271724182" WEIGHT="8.437244748668657"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4768087247663102" CI_END="1.1514417963364671" CI_START="1.0260890141864982" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0869598786045491" ESTIMABLE="YES" EVENTS_1="1412" EVENTS_2="1214" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.06124198991748067" LOG_CI_START="0.011185037864621862" LOG_EFFECT_SIZE="0.036213513891051256" METHOD="MH" MODIFIED="2010-08-25 11:06:53 -0700" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9157304906620685" P_Q="0.0" P_Z="0.004570288129777726" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="6379" TOTAL_2="6073" WEIGHT="100.00000000000001" Z="2.835857161464865">
<NAME>Safer sexual behaviour</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.354756653778691" CI_START="0.9064197339539779" DF="0" EFFECT_SIZE="1.1081417624521073" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="135" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.131861292692196" LOG_CI_START="-0.04267064787764221" LOG_EFFECT_SIZE="0.04459532240727692" NO="1" P_CHI2="1.0" P_Z="0.31653888325859514" STUDIES="1" TAU2="0.0" TOTAL_1="464" TOTAL_2="503" WEIGHT="10.33695624656211" Z="1.0015957596281924">
<NAME>Reduced frequency of partner change</NAME>
<DICH_DATA CI_END="1.354756653778691" CI_START="0.9064197339539779" EFFECT_SIZE="1.1081417624521073" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="135" LOG_CI_END="0.131861292692196" LOG_CI_START="-0.04267064787764221" LOG_EFFECT_SIZE="0.04459532240727692" ORDER="21836" O_E="0.0" SE="0.10252092583776234" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="464" TOTAL_2="503" VAR="0.010510540234631967" WEIGHT="10.33695624656211"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.23395034586813965" CI_END="1.1802599697873077" CI_START="1.0532016761377427" DF="1" EFFECT_SIZE="1.11492231947265" ESTIMABLE="YES" EVENTS_1="666" EVENTS_2="533" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.07197767765260511" LOG_CI_START="0.022511541600754185" LOG_EFFECT_SIZE="0.04724460962667963" MODIFIED="2010-08-19 09:45:38 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.628610075267793" P_Z="1.8119745855150874E-4" STUDIES="2" TAU2="0.0" TOTAL_1="840" TOTAL_2="751" WEIGHT="44.9434891639241" Z="3.7438838252854207">
<NAME>Regular condom use with casual partners</NAME>
<DICH_DATA CI_END="1.1757346727904057" CI_START="1.0392630722251848" EFFECT_SIZE="1.1053947838513756" ESTIMABLE="YES" EVENTS_1="510" EVENTS_2="405" LOG_CI_END="0.0703093258693714" LOG_CI_START="0.016725495925001364" LOG_EFFECT_SIZE="0.04351741089718637" MODIFIED="2010-08-19 09:45:38 -0700" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.031475406953559014" STUDY_ID="STD-Gregson-2007" TOTAL_1="622" TOTAL_2="546" VAR="9.90701242892151E-4" WEIGHT="34.41675879844358"/>
<DICH_DATA CI_END="1.3119691680840235" CI_START="1.0011527930043018" EFFECT_SIZE="1.146072247706422" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="128" LOG_CI_END="0.11792362902720918" LOG_CI_START="5.003632882762563E-4" LOG_EFFECT_SIZE="0.059211996157742704" MODIFIED="2010-08-18 09:16:41 -0700" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.06897500754958895" STUDY_ID="STD-Kamali-2003" TOTAL_1="218" TOTAL_2="205" VAR="0.004757551666465853" WEIGHT="10.526730365480514"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.277068721141956" CI_END="1.172687519275267" CI_START="0.9472550948884051" DF="2" EFFECT_SIZE="1.0539612077043166" ESTIMABLE="YES" EVENTS_1="608" EVENTS_2="546" I2="0.0" ID="CMP-003.03.03" LOG_CI_END="0.06918230305015693" LOG_CI_START="-0.02353305015856996" LOG_EFFECT_SIZE="0.022824626445793493" MODIFIED="2010-08-18 09:18:10 -0700" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8706333440164513" P_Z="0.33454171363922947" STUDIES="3" TAU2="0.0" TOTAL_1="5075" TOTAL_2="4819" WEIGHT="44.719554589513805" Z="0.9650062097832779">
<NAME>Two or more sexual partners within the past year</NAME>
<DICH_DATA CI_END="1.261571348848748" CI_START="0.790647090620141" EFFECT_SIZE="0.9987280493592786" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="129" LOG_CI_END="0.10091181730706811" LOG_CI_START="-0.10201732281946851" LOG_EFFECT_SIZE="-5.527527562002171E-4" MODIFIED="2010-08-18 09:18:10 -0700" MODIFIED_BY="[Empty name]" ORDER="42" O_E="0.0" SE="0.11920158142577188" STUDY_ID="STD-Gregson-2007" TOTAL_1="2450" TOTAL_2="2304" VAR="0.014209017014404924" WEIGHT="10.608745240309158"/>
<DICH_DATA CI_END="1.4962093396158673" CI_START="0.7814475457467053" EFFECT_SIZE="1.0812997347480107" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="65" LOG_CI_END="0.1749923613624036" LOG_CI_START="-0.1071001684538906" LOG_EFFECT_SIZE="0.03394609645425652" MODIFIED="2010-08-18 09:17:30 -0700" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.16570254839463439" STUDY_ID="STD-Grosskurth-1995" TOTAL_1="464" TOTAL_2="526" VAR="0.02745733454447615" WEIGHT="4.8614245033869175"/>
<DICH_DATA CI_END="1.2164935613712338" CI_START="0.9401810791326034" EFFECT_SIZE="1.0694504333010812" ESTIMABLE="YES" EVENTS_1="409" EVENTS_2="352" LOG_CI_END="0.08510981464920951" LOG_CI_START="-0.026788493108399355" LOG_EFFECT_SIZE="0.029160660770405068" MODIFIED="2010-08-18 09:17:53 -0700" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.06572961988237612" STUDY_ID="STD-Kamali-2003" TOTAL_1="2161" TOTAL_2="1989" VAR="0.0043203829298816545" WEIGHT="29.249384845817726"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-02-16 22:17:13 -0800" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="flow.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2011-02-16 17:30:32 -0800" MODIFIED_BY="Tara Horvath" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow chart depicting screening process</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAXAAAAM9CAYAAACFQCikAACAAElEQVR42uzda4xd13UneAMSMOjW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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-02-16 22:17:13 -0800" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASkAAAFiCAIAAAAlZLl6AAAP40lEQVR42u3dsW4UyRbG8ZFICBw4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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2011-02-16 22:17:13 -0800" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAfMAAADnCAMAAAA94U9AAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2011-02-14 15:35:36 -0800" MODIFIED_BY="Tara Horvath">
<APPENDIX ID="APP-01" MODIFIED="2011-02-14 15:35:36 -0800" MODIFIED_BY="Tara Horvath" NO="1">
<TITLE MODIFIED="2011-02-14 15:29:38 -0800" MODIFIED_BY="Tara Horvath">PubMed search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2011-02-14 15:35:36 -0800" MODIFIED_BY="Tara Horvath">
<TABLE COLS="2" ROWS="12">
<TR>
<TD>
<P>
<B>Search #</B>
</P>
</TD>
<TD>
<P>
<B>Example of search strategy used in PubMed (This strategy was modified as appropriate for use in the other databases)</B>
</P>
<P>
<B>1 Jan 1980 - 16 Aug 2010</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>#11</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Search #8 AND #9 AND #10</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#10</P>
</TD>
<TD VALIGN="TOP">
<P>Search (POPULATION OR POPULATIONS OR POPULATION-BASED OR (POPULATION BASED) OR (COMMUNITY BASED) OR COMMUNITY-BASED OR COMMUNITY OR COMMUNITIES) AND (INTERVENTION OR INTERVENTIONS)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#9</P>
</TD>
<TD VALIGN="TOP">
<P>Search randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR ("clinical trial" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ( placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR (comparative study) OR (comparative studies) OR (evaluation studies) OR (evaluation study) OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh])</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#8</P>
</TD>
<TD VALIGN="TOP">
<P>Search #1 OR #7</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#7</P>
</TD>
<TD VALIGN="TOP">
<P>Search #2 OR #3 OR #4 OR #5 OR #16</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#6</P>
</TD>
<TD VALIGN="TOP">
<P>Search GENITAL ULCER OR GENITAL ULCERS OR GENITAL ULCER DISEASE OR GENITAL ULCER DISEASES</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#5</P>
</TD>
<TD VALIGN="TOP">
<P>Search SEXUALLY TRANSMITTED INFECTION OR SEXUALLY TRANSMITTED INFECTIONS</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#4</P>
</TD>
<TD VALIGN="TOP">
<P>Search SEXUALLY TRANSMITTED DISEASES, VIRAL[MeSH] OR VIRAL SEXUALLY TRANSMITTED DISEASE OR VENEREAL DISEASES, VIRAL OR VIRAL VENEREAL DISEASES OR DISEASE, VIRAL VENEREAL OR DISEASES, VIRAL VENEREAL OR VENEREAL DISEASE, VIRAL OR VIRAL VENEREAL DISEASE OR VIRAL SEXUALLY TRANSMITTED DISEASES[MeSH]</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#3</P>
</TD>
<TD VALIGN="TOP">
<P>Search BACTERIAL VENEREAL DISEASES OR BACTERIAL VENEREAL DISEASE OR DISEASE, BACTERIAL VENEREAL OR DISEASES, BACTERIAL VENEREAL OR VENEREAL DISEASE, BACTERIAL OR VENEREAL DISEASES, BACTERIAL OR BACTERIAL SEXUALLY TRANSMITTED DISEASE OR BACTERIAL SEXUALLY TRANSMITTED DISEASES OR SEXUALLY TRANSMITTED DISEASE, BACTERIAL[MeSH]</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#2</P>
</TD>
<TD VALIGN="TOP">
<P>Search DISEASE, SEXUALLY TRANSMITTED OR DISEASES, SEXUALLY TRANSMITTED OR SEXUALLY TRANSMITTED DISEASE OR SEXUALLY TRANSMITTED DISEASES OR VENEREAL DISEASES OR DISEASE, VENEREAL OR DISEASES, VENEREAL OR VENEREAL DISEASE OR STDs OR STI OR STIs</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>#1</P>
</TD>
<TD VALIGN="TOP">
<P>Search (HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR "sexually transmitted diseases, viral"[MESH:noexp])</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2010-08-20 09:44:46 -0700" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-08-20 09:44:42 -0700" MODIFIED_BY="[Empty name]">The Cochrane Collaboration's tool for assessing risk of bias</TITLE>
<APPENDIX_BODY MODIFIED="2010-08-20 09:44:46 -0700" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="7">
<TR>
<TD>
<P>
<B>Domain</B>
</P>
</TD>
<TD>
<P>
<B>Description</B>
</P>
</TD>
<TD>
<P>
<B>Review authors' judgement</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Sequence generation.</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Describe the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
</TD>
<TD VALIGN="TOP">
<P>Was the allocation sequence adequately generated?</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Allocation concealment.</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Describe the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocations could have been foreseen in advance of, or during, enrolment.</P>
</TD>
<TD VALIGN="TOP">
<P>Was allocation adequately concealed?</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Blinding of participants, personnel and outcome assessors<I> </I>
</B>
<I>Assessments should be made for each main outcome (or class of outcomes).</I>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Describe all measures used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Provide any information relating to whether the intended blinding was effective.</P>
</TD>
<TD VALIGN="TOP">
<P>Was knowledge of the allocated intervention adequately prevented during the study?</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Incomplete outcome data </B>
<I>Assessments should be made for each main outcome (or class of outcomes).</I>
<B> </B>
</P>
</TD>
<TD VALIGN="TOP">
<P>Describe the completeness of outcome data for each main outcome, including attrition and exclusions from the analysis. State whether attrition and exclusions were reported, the numbers in each intervention group (compared with total randomised participants), reasons for attrition/exclusions where reported, and any re-inclusions in analyses performed by the review authors.</P>
</TD>
<TD VALIGN="TOP">
<P>Were incomplete outcome data adequately addressed?</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Selective outcome reporting.</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>State how the possibility of selective outcome reporting was examined by the review authors, and what was found.</P>
</TD>
<TD VALIGN="TOP">
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<B>Other sources of bias.</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>State any important concerns about bias not addressed in the other domains in the tool.</P>
<P>If particular questions/entries were pre-specified in the review's protocol, responses should be provided for each question/entry.</P>
</TD>
<TD VALIGN="TOP">
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>